Просмотр новости
Найдите то, что Вас интересует
Спутники
РН
SpaceX
Роскосмос
NASA
Anatomic Pathology Market by Product [Consumables (Histopathology, Cytopathology), Instruments, Software], Process, Disease (Breast, GI, Prostate), End User (Hospitals, Research Labs), Services, Model (In House, Outsourced) Global Forecast to 2031..., Market Research Report: MarketsandMarkets
Дата публикации: 07-08-2026 00:00:00
Основное содержимое страницы с новостью.
Anatomic Pathology Market by Product [Consumables (Histopathology, Cytopathology), Instruments, Software], Process, Disease (Breast, GI, Prostate), End User (Hospitals, Research Labs), Services, Model (In House, Outsourced) Global Forecast to 2031
2026-2031
FORECAST PERIOD
ANATOMIC PATHOLOGY MARKET SIZE, SHARE & GROWTH SNAPSHOT
Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis
The global anatomic pathology market is projected to grow from USD 8.9 billion in 2026 to USD 14.5 billion by 2031, at a CAGR of 10.2% during the forecast period. The market was valued at USD 8.2 billion in 2025. Market growth is primarily driven by the increasing global burden of cancer and the growing demand for accurate tissue and cell-based diagnosis across a wide range of diseases. Rising adoption of biomarker assessment, enhanced focus on disease characterization, and expanding utilization of histopathology and cytopathology services are supporting market expansion. Additionally, advancements in laboratory automation, digital pathology, artificial intelligence-enabled image analysis, and integrated pathology workflows are improving diagnostic efficiency and consistency. Increasing healthcare expenditure, expanding access to specialized pathology services, and ongoing investments in precision diagnostics and pathology infrastructure are further contributing to the sustained growth of the anatomic pathology market.
KEY TAKEAWAYS
-
MARKET SNAPSHOT:
Base Year Market Size (2025): USD 8.2 Billion
Current Market Size (2026): USD 8.9 Billion
Forecast Market Size (2031): USD 14.5 Billion
CAGR (2026–2031): 10.2% -
SEGMENT LEADERSHIP:
Regional Leader: North America led the market in 2025.
Type Leader: Consumables segment held the largest market share of 58.7% in 2025.
Process Leader: Preanalytics/sample preparation segment held the largest market share in 2025.
Disease Leader: Breast cancer is expected to be the fastest-growing segment from 2026 to 2031.
End User Leader: Hospitals led the market with a share of 54.9% in 2025. -
MARKET OUTLOOK & COMPETITIVE LANDSCAPE:
F. Hoffmann-La Roche Ltd. (Switzerland), Danaher Corporation (US), PHC Holdings Corporation (Japan), Hologic, Inc. (US), and Agilent Technologies, Inc. (US) were identified as star players in the anatomic pathology market, owing to their strong market presence and extensive product portfolios.
Proscia (US), Instapath (US), Gestalt Diagnostics (US), Lumea (US), and Tribun Health (France), among others, have distinguished themselves among startups and SMEs by securing strong footholds in specialized niche areas.
The anatomic pathology market is expected to grow steadily due to increasing reliance on tissue-based diagnostics for detecting, classifying, and monitoring various diseases, particularly cancer. Continuous advancements in pathology technologies, laboratory automation, digital pathology platforms, and artificial intelligence-assisted diagnostic tools are improving workflow efficiency, diagnostic accuracy, and operational consistency across pathology laboratories. Furthermore, growing investments in precision healthcare, disease characterization, and pathology infrastructure modernization are expanding the role of anatomic pathology in clinical decision-making and research applications. The increasing availability of specialized pathology services and advanced diagnostic capabilities across healthcare systems is also expected to support long-term market expansion.
TRENDS & DISRUPTIONS IMPACTING CUSTOMERS' CUSTOMERS
The anatomic pathology market is experiencing steady growth due to the increasing volume of tissue-based diagnostic procedures performed worldwide and the growing emphasis on accurate disease diagnosis and classification. Rising numbers of biopsies, surgical resections, and cytology examinations are generating sustained demand for pathology services and associated technologies across healthcare settings. Furthermore, expanding pathology laboratory networks, increasing investments in healthcare infrastructure, and the growing need for standardized diagnostic workflows are supporting the adoption of advanced anatomic pathology solutions. These factors, combined with ongoing improvements in pathology capabilities and access to specialized diagnostic services, are expected to drive continued market expansion over the forecast period.
Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis
MARKET DYNAMICS
-
High cost of instruments and consumables
OPPORTUNITIES
Impact
Level
Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis
The growing global burden of cancer is a major factor driving demand for anatomic pathology products and services. Rising cancer incidence, coupled with the rapid expansion of the aging population, is increasing the need for accurate and timely pathological diagnosis worldwide. Additionally, growing awareness of early cancer detection and increasing government initiatives aimed at improving access to cancer care are supporting the adoption of anatomic pathology solutions. As cancer cases continue to rise globally, the demand for histopathology, cytopathology, and advanced tissue-based diagnostic technologies is expected to grow significantly.
The high cost of anatomic pathology instruments and associated consumables remains a significant challenge for market growth, particularly among small and mid-sized laboratories. Advanced systems such as tissue processors, slide scanners, staining platforms, and microtomes require substantial capital investment, while ongoing expenses for reagents, antibodies, and other consumables further increase operational costs. These financial constraints can limit technology adoption, especially in resource-constrained healthcare settings, thereby restricting market expansion to some extent.
Rapid improvements in healthcare infrastructure, increasing investments in pathology laboratory modernization, and the expansion of specialized cancer care services are creating favorable conditions for the adoption of advanced anatomic pathology solutions. Many emerging countries are strengthening their diagnostic capabilities by expanding pathology networks and upgrading laboratory facilities to address rising disease burdens, leading to increased demand for tissue processing systems, staining platforms, digital pathology technologies, and related solutions. In addition, the growing presence of private healthcare providers, cancer centers, and diagnostic laboratory chains is improving access to high-quality pathology services, creating new growth opportunities for the anatomic pathology market across these regions.
Manufacturers must navigate complex regulatory pathways that differ across countries and regions, often requiring extensive clinical validation, documentation, and approval processes before products can be commercialized. Variations in regulatory standards can increase development timelines, delay product launches, and raise compliance costs for diagnostic companies. In addition, evolving requirements for specialized assays, biomarkers, and analytical platforms may create uncertainty for manufacturers seeking to expand their product portfolios across multiple geographic markets.
ANATOMIC PATHOLOGY MARKET: COMMERCIAL USE CASES ACROSS INDUSTRIES
| COMPANY | USE CASE DESCRIPTION | BENEFITS |
|---|---|---|
|
|
Offers comprehensive anatomic pathology solutions through tissue processors, microtomes, staining systems, digital pathology scanners, and workflow automation platforms used for histopathology, immunohistochemistry (IHC), and cancer diagnostics. | Improves laboratory efficiency, enhances diagnostic accuracy, supports workflow standardization, and enables high-throughput pathology operations. |
|
|
Provides tissue diagnostics solutions through its portfolio, including automated IHC and ISH staining systems, digital pathology platforms, image analysis software, and biomarker testing solutions for cancer diagnosis and tissue characterization. | Enables precise tissue analysis, supports personalized treatment decisions, improves pathology workflow productivity, and enhances diagnostic confidence. |
|
|
Offers a broad portfolio of histology and cytology products, including tissue processors, microtomes, cryostats, slide printers, staining systems, and pathology workflow solutions for specimen preparation and analysis. | Enhances specimen traceability, improves laboratory productivity, streamlines tissue preparation workflows, and supports consistent diagnostic outcomes. |
|
|
Provides anatomic pathology consumables and instruments, including antibodies, reagents, automated staining platforms, IHC and ISH solutions, and biomarker testing products used in cancer diagnostics and pathology laboratories. | Delivers high-quality staining performance, supports biomarker analysis, improves laboratory efficiency, and enables accurate tissue-based diagnosis. |
|
|
Offers cytopathology and digital diagnostics solutions, including ThinPrep sample preparation systems and Genius Digital Diagnostics platforms for cervical cancer screening and cytology testing workflows. | Improves screening efficiency, enhances diagnostic accuracy, supports automated review processes, and increases laboratory throughput. |
Logos and trademarks shown above are the property of their respective owners. Their use here is for informational and illustrative purposes only.
MARKET ECOSYSTEM
In the anatomic pathology industry, interactions among manufacturers, hospitals, diagnostic laboratories, cancer centers, research institutions, and contract research organizations facilitate accurate diagnosis and disease characterization through tissue and cellular analysis. Manufacturers develop and supply tissue processing systems, staining platforms, digital pathology solutions, imaging technologies, reagents, antibodies, and other consumables that enable pathology laboratories to perform histopathology, cytopathology, immunohistochemistry (IHC), and molecular pathology procedures. Pathologists, laboratory professionals, clinicians, and researchers rely on these technologies to support disease diagnosis, treatment planning, biomarker assessment, and scientific research. The industry continues to evolve through advancements in digital pathology, laboratory automation, artificial intelligence, and tissue analysis technologies, supported by regulatory standards, laboratory accreditation requirements, and collaborations among industry participants, healthcare providers, and academic institutions. Ongoing efforts toward workflow standardization, quality assurance, and diagnostic accuracy are further supporting the adoption of advanced anatomic pathology solutions across healthcare settings.
Logos and trademarks shown above are the property of their respective owners. Their use here is for informational and illustrative purposes only.
MARKET SEGMENTS
Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis
The anatomic pathology market, by product, is segmented into consumables, instruments, software, and storage systems. The consumables segment accounted for the largest market share in 2025. This segment includes antibodies, probes, stains, reagents, assay kits, fixatives, solvents, and other laboratory consumables used across histopathology and cytopathology workflows. The recurring nature of pathology testing generates consistent demand for consumables, as each specimen requires multiple products throughout tissue preparation, staining, biomarker assessment, and diagnostic evaluation processes. Furthermore, the growing volume of pathology examinations, increasing complexity of diagnostic workflows, and expanding use of advanced tissue analysis techniques continue to drive consumable utilization, reinforcing their importance across hospitals, diagnostic laboratories, cancer centers, and research institutions.
The anatomic pathology market, by process, is segmented into preanalytics/sample preparation, advanced staining/IHC, primary & special staining, and digital pathology. Preanalytics/sample preparation accounted for the largest market share in 2025, as it forms the foundation of all pathology workflows and is required for every tissue and cytology specimen processed. The segment's dominance is supported by increasing specimen volumes and growing demand for standardized laboratory workflows. Meanwhile, Digital Pathology is the fastest-growing segment, driven by increasing adoption of whole-slide imaging, remote diagnostics, and AI-enabled pathology solutions.
The anatomic pathology market, by disease type, is segmented into breast cancer, gastric cancer, lymphoma, prostate cancer, non-small-cell lung cancer (NSCLC), and other diseases. Breast cancer accounted for the largest market share in 2025 due to its high global incidence and the extensive use of anatomic pathology techniques for diagnosis, classification, grading, and treatment planning. Histopathology, cytopathology, immunohistochemistry (IHC), and biomarker assessment are routinely utilized in breast cancer evaluation, contributing to significant demand for anatomic pathology products and services. The growing focus on early detection and accurate disease characterization has further strengthened the segment's position within the market.
The anatomic pathology market, by end user, is segmented into hospitals, research laboratories, pharmaceutical companies, contract research organizations (CROs), and other end users. Hospitals accounted for the largest market share in 2025 due to the high volume of pathology testing performed for disease diagnosis, treatment planning, and patient management. The increasing number of cancer cases, growing demand for tissue-based diagnostics, and expanding adoption of advanced pathology technologies have strengthened the role of hospitals as the primary end users of anatomic pathology solutions. Furthermore, ongoing investments in pathology infrastructure, laboratory modernization, and integrated diagnostic services continue to support market growth across hospital-based laboratories.
By type, the anatomic pathology services market is segmented into histopathology services and cytopathology services. Histopathology services represent the largest segment due to their extensive use in disease diagnosis, tissue characterization, cancer detection, and treatment planning across hospitals, diagnostic laboratories, and cancer centers. The analysis of biopsy and surgical tissue specimens remains a fundamental component of clinical decision-making, driving substantial demand for histopathology services. Furthermore, increasing cancer incidence, rising biopsy volumes, and the growing adoption of advanced staining and tissue evaluation techniques are supporting the continued dominance of the histopathology services segment within the market.
The anatomic pathology market, by model, is segmented into in-house and outsourced services. In-house services represent the largest segment due to the widespread availability of pathology laboratories within hospitals, academic medical centers, and large diagnostic networks. Many healthcare institutions perform histopathology, cytopathology, and related diagnostic procedures internally to maintain greater control over turnaround times, diagnostic quality, and workflow efficiency. The increasing adoption of advanced pathology technologies, laboratory automation, and digital pathology solutions has further strengthened in-house testing capabilities, enabling healthcare providers to manage growing specimen volumes while supporting timely clinical decision-making and patient care.
The anatomic pathology services market, by disease type, is segmented into breast cancer, gastric cancer, lymphoma, prostate cancer, non-small-cell lung cancer (NSCLC), and other disease types. Breast cancer accounted for the largest market share in 2025 due to the high volume of screening programs, biopsy procedures, and pathological evaluations performed for disease detection and management. The widespread implementation of population-based screening initiatives, increasing awareness regarding early diagnosis, and the need for detailed pathological assessment throughout the patient care pathway continue to drive demand for breast cancer-related pathology services. Additionally, the growing incidence of breast cancer globally has further strengthened the segment's leading position within the anatomic pathology services market.
REGION
Asia Pacific to be fastest-growing regional segment in anatomic pathology market during forecast period
The Asia Pacific is expected to register the fastest growth during the forecast period, driven by the expansion of cancer care infrastructure, increasing availability of pathology services, and rising investments in healthcare capacity across emerging economies. The growing number of diagnostic laboratories, improving access to specialized healthcare services, and increasing focus on strengthening diagnostic capabilities are further accelerating market growth throughout the region.
ANATOMIC PATHOLOGY MARKET: COMPANY EVALUATION MATRIX
Danaher Corporation is a leading participant in the anatomic pathology market through its Leica Biosystems business, which offers a comprehensive portfolio of solutions spanning tissue processing, embedding, microtomy, staining, digital pathology, and workflow automation. The company's product portfolio includes advanced tissue processors, slide staining systems, coverslippers, pathology imaging platforms, and digital pathology solutions that support efficient and standardized diagnostic workflows. Danaher further strengthens its market position through continuous product innovation, strategic collaborations, and investments in laboratory automation and digital pathology technologies, enabling pathology laboratories to improve productivity, diagnostic accuracy, and operational efficiency. Sakura Finetek is a prominent participant in the anatomic pathology market, offering a broad range of solutions for tissue processing, embedding, sectioning, staining, and pathology workflow management. The company's portfolio includes automated tissue processors, microtomes, embedding systems, slide staining platforms, and laboratory workflow solutions designed to enhance specimen quality and laboratory efficiency. Sakura Finetek continues to strengthen its position through ongoing innovation in pathology automation, workflow optimization, and specimen management technologies, helping pathology laboratories improve turnaround times, standardization, and overall diagnostic performance.
Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis
KEY MARKET PLAYERS
MARKET SCOPE
| REPORT METRIC | DETAILS |
|---|---|
| Market Size in 2025 (Value) | USD 8.2 Billion |
| Market Forecast in 2026 (Value) | USD 8.9 Billion |
| Market Forecast in 2031 (Value) | USD 14.5 Billion |
| CAGR | CAGR of 10.2% from 2026–2031 |
| Years Considered | 2024–2031 |
| Base Year | 2025 |
| Forecast Period | 2026–2031 |
| Units Considered | Value (USD Million/Billion), Volume (Number of Tests) |
| Report Coverage | Revenue Forecast, Company Ranking, Competitive Landscape, Growth Factors, and Trends |
| Segments Covered |
|
| Regions Covered | North America, Europe, Asia Pacific, Latin America, Middle East & Africa |
WHAT IS IN IT FOR YOU: ANATOMIC PATHOLOGY MARKET REPORT CONTENT GUIDE
DELIVERED CUSTOMIZATIONS
We have successfully delivered the following deep-dive customizations:
| CLIENT REQUEST | CUSTOMIZATION DELIVERED | VALUE ADDS |
|---|---|---|
| Product Analysis | Product matrix, which provides a detailed comparison of the product portfolio of each company in the anatomic pathology market. | Enables easy comparison of competitors’ offerings, helping identify gaps, overlaps, and differentiation opportunities. |
| Company Information | Additional five company profiles of players operating in the anatomic pathology market. | Provides insights into competitors’ strategies, innovation focus, and partnerships, supporting strategic planning. |
RECENT DEVELOPMENTS
- May 2026 : Roche (Switzerland) announced the acquisition of PathAI, a provider of digital pathology and artificial intelligence technologies. The acquisition is expected to strengthen Roche’s digital pathology portfolio by enhancing AI-powered image analysis capabilities and accelerating the adoption of precision diagnostics and companion diagnostic solutions within pathology workflows.
- March 2026 : Agilent Technologies (US) announced the acquisition of Biocare Medical, a global provider of clinical pathology solutions. The acquisition expands Agilent’s pathology portfolio through the addition of complementary immunohistochemistry (IHC), in situ hybridization (ISH), fluorescence in situ hybridization (FISH), antibody, reagent, and instrument offerings, strengthening the company’s position in the anatomic pathology market.
- January 2024 : Epredia (US), a subsidiary of PHC Holdings Corporation, launched the SlideMate Laser slide printer for pathology laboratories. The solution was designed to improve tissue sample traceability, workflow efficiency, and laboratory productivity, thereby strengthening Epredia’s precision cancer diagnostics portfolio.
Table of Contents
Exclusive indicates content/data unique to MarketsandMarkets and not available with any competitors.
4
MARKET OVERVIEW
Digital pathology demand and personalized medicine drive market expansion amid regulatory and cost challenges.57
4.2.1.1
HIGH INCIDENCE OF CANCER AND OTHER TARGET DISEASES
4.2.1.2
GROWING DEMAND FOR DIGITAL PATHOLOGY
4.2.1.3
AVAILABILITY OF REIMBURSEMENT
4.2.1.4
GROWING FOCUS ON PERSONALIZED MEDICINE
4.2.2.1
HIGH COST OF INSTRUMENTS AND CONSUMABLES
4.2.3.1
EXPANSION POTENTIAL ACROSS EMERGING ECONOMIES
4.2.3.2
INCREASING NUMBER OF CLINICAL TRIALS FOR CANCER THERAPEUTICS
4.2.4.1
AVAILABILITY OF REFURBISHED PRODUCTS
4.2.4.2
STRINGENT REGULATORY REQUIREMENTS
4.2.4.3
SHORTAGE OF SKILLED PROFESSIONALS
4.3
UNMET NEEDS & WHITE SPACES
4.3.1
UNMET NEEDS IN ANATOMIC PATHOLOGY MARKET
4.3.2
WHITE SPACE OPPORTUNITIES
4.4
INTERCONNECTED MARKETS & CROSS-SECTOR OPPORTUNITIES
4.4.1
INTERCONNECTED MARKETS
4.4.2
CROSS-SECTOR OPPORTUNITIES
4.5
STRATEGIC MOVES BY TIER 1/2/3 PLAYERS
4.5.1
KEY MOVES & STRATEGIC FOCUS
5
INDUSTRY TRENDS
Navigate shifting market dynamics with insights from comprehensive industry trend analysis and competitive forces.69
5.1
PORTER’S FIVE FORCES ANALYSIS
5.1.1
BARGAINING POWER OF SUPPLIERS
5.1.2
BARGAINING POWER OF BUYERS
5.1.3
THREAT OF NEW ENTRANTS
5.1.4
THREAT OF SUBSTITUTES
5.1.5
INTENSITY OF COMPETITIVE RIVALRY
5.2
MACROECONOMIC INDICATORS
5.2.2
GDP TRENDS & FORECAST
5.3
SUPPLY CHAIN ANALYSIS
5.5.1
ANATOMIC PATHOLOGY MARKET: ROLE OF COMPANIES IN ECOSYSTEM
AVERAGE SELLING PRICE OF ANATOMIC PATHOLOGY PRODUCTS,
AVERAGE SELLING PRICE OF ANATOMIC PATHOLOGY PRODUCTS,
5.7.1
IMPORT SCENARIO (HS CODE 3822)
5.7.2
EXPORT SCENARIO (HS CODE 3822)
5.8
KEY CONFERENCES & EVENTS, 2026–2027
5.9
TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES
5.10
INVESTMENT & FUNDING SCENARIO
CASE STUDY 1: OPTIMIZING AUTOMATED TISSUE PROCESSING
5.11.2
CASE STUDY 2: OPERATIONAL EFFICIENCY IMPROVEMENTS THROUGH MILESTONE MEDICAL TISSUE PROCESSOR IMPLEMENTATION
CASE STUDY 3: WORKFLOW OPTIMIZATION THROUGH EXCELSIOR
5.12
IMPACT OF 2025 US TARIFFS ON ANATOMIC PATHOLOGY MARKET
5.12.3
PRICE IMPACT ANALYSIS
5.12.5
IMPACT ON END-USE INDUSTRIES
5.12.5.2
RESEARCH LABORATORIES
5.12.5.3
PHARMACEUTICAL COMPANIES
5.12.5.4
CONTRACT RESEARCH ORGANIZATIONS (CROS)
6
TECHNOLOGICAL ADVANCEMENTS, AI-DRIVEN IMPACT, PATENTS, INNOVATIONS, AND FUTURE APPLICATIONS
AI and innovative technologies redefine anatomic pathology, driving sustainable, high-performance market shifts.89
6.1
KEY EMERGING TECHNOLOGIES
6.2
COMPLEMENTARY TECHNOLOGIES
6.3
ADJACENT TECHNOLOGIES
6.3.1
MASS SPECTROMETRY IMAGING (MSI)
6.4
TECHNOLOGY/PRODUCT ROADMAP
SHORT-TERM (2025–2027) | OPTIMIZATION & STANDARDIZATION
6.4.1.1
CORE TECHNOLOGY DEVELOPMENT
6.4.1.2
PRODUCT INNOVATIONS
6.4.2
MID-TERM (2027–2030) | EXPANDED CAPABILITIES & SUSTAINABILITY
6.4.2.1
ADVANCED TECHNOLOGY DEVELOPMENT
6.4.2.2
PRODUCT INNOVATIONS
6.4.3
LONG-TERM (2030–2035+) | HIGH-PERFORMANCE & ECO-EFFICIENT PRODUCTS
6.4.3.1
HIGH-PERFORMANCE & INTEGRATED WORKFLOWS
6.4.3.2
PRODUCT INNOVATIONS
6.5.1
LIST OF MAJOR PATENTS
6.5.1.1
LIST OF KEY PATENTS
6.7
IMPACT OF AI/GENERATIVE AI ON ANATOMIC PATHOLOGY MARKET
6.7.2
TOP USE CASES & MARKET POTENTIAL
6.7.3
KEY COMPANIES IMPLEMENTING AI
7
SUSTAINABILITY & REGULATORY LANDSCAPE
Navigate complex global regulations to drive sustainable compliance and eco-friendly innovations.97
7.1
REGIONAL REGULATIONS & COMPLIANCE
7.1.1
REGULATORY ANALYSIS
7.1.2
REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
7.2
SUSTAINABILITY INITIATIVES
ENVIRONMENTAL IMPACT AND ECO-FRIENDLY INITIATIVES
7.2.1.1
ECO-FRIENDLY INITIATIVES
7.3
SUSTAINABILITY IMPACT & REGULATORY POLICY INITIATIVES
8
CUSTOMER LANDSCAPE & BUYER BEHAVIOR
Unlock market profitability by addressing unmet needs and overcoming adoption barriers in key industries.106
8.1
DECISION-MAKING PROCESS
8.2
BUYER STAKEHOLDERS & BUYING EVALUATION CRITERIA
8.2.1
KEY STAKEHOLDERS IN BUYING PROCESS
8.3
ADOPTION BARRIERS & INTERNAL CHALLENGES
8.4
UNMET NEEDS IN VARIOUS END-USE INDUSTRIES
8.5.3
MARGIN OPPORTUNITIES IN KEY APPLICATIONS
9
ANATOMIC PATHOLOGY PRODUCT MARKET, BY TYPE
Market Size & Growth Rate Forecast Analysis to 2031 in USD Million | 142 Data Tables112
9.2.1
HISTOPATHOLOGY CONSUMABLES
9.2.1.1
HISTOPATHOLOGY ANTIBODIES
9.2.1.1.1
PRIMARY HISTOPATHOLOGY ANTIBODIES
9.2.1.1.2
SECONDARY HISTOPATHOLOGY ANTIBODIES
9.2.1.2
HISTOPATHOLOGY KITS & REAGENTS
9.2.1.2.1
HISTOPATHOLOGY STAINS & SOLVENTS
9.2.1.2.2
HISTOPATHOLOGY FIXATIVES
9.2.1.2.3
OTHER HISTOPATHOLOGY KITS & REAGENTS
9.2.1.3
HISTOPATHOLOGY PROBES
9.2.1.3.1
GROWING ADOPTION OF TISSUE-BASED PATHOLOGY AND PRECISION DIAGNOSTICS TO DRIVE DEMAND FOR HISTOPATHOLOGY PROBES
9.2.1.4
OTHER HISTOPATHOLOGY CONSUMABLES
9.2.2
CYTOPATHOLOGY CONSUMABLES
9.2.2.1
CYTOPATHOLOGY ANTIBODIES
9.2.2.1.1
PRIMARY CYTOPATHOLOGY ANTIBODIES
9.2.2.1.2
SECONDARY CYTOPATHOLOGY ANTIBODIES
9.2.2.2
CYTOPATHOLOGY KITS & REAGENTS
9.2.2.2.1
CYTOPATHOLOGY STAINS & SOLVENTS
9.2.2.2.2
CYTOPATHOLOGY FIXATIVES
9.2.2.2.3
OTHER CYTOPATHOLOGY KITS & REAGENTS
9.2.2.3
CYTOPATHOLOGY PROBES
9.2.2.3.1
INCREASING RESEARCH TO AID MARKET GROWTH
9.2.2.4
OTHER CYTOPATHOLOGY CONSUMABLES
9.3.1
SLIDE STAINING SYSTEMS
9.3.1.1
AVAILABILITY OF AUTOMATED SYSTEMS TO DRIVE MARKET GROWTH
9.3.2
TISSUE PROCESSING SYSTEMS
9.3.2.1
RISING ADOPTION OF AUTOMATION TO DRIVE MARKET GROWTH
9.3.3.1
TECHNOLOGICAL ADVANCEMENTS IN CYTOPATHOLOGY TESTING TO SUPPORT GROWTH OF THIS MARKET
9.3.4.1
INCREASING DEMAND FOR ACCURATE TISSUE SECTIONING TO SUPPORT GROWTH
9.3.5.1
ADVANCEMENTS IN TISSUE PREPARATION TECHNOLOGIES TO SUPPORT EXPANSION OF EMBEDDING SYSTEMS MARKET
9.3.6.1
INCREASING FOCUS ON LABORATORY AUTOMATION AND WORKFLOW EFFICIENCY TO DRIVE GROWTH OF COVERSLIPPERS MARKET
9.3.7
DIGITAL PATHOLOGY SCANNERS
9.3.7.1
GROWING ADOPTION OF DIGITAL IMAGING TO PROPEL MARKET
9.4.1
AI-INTEGRATED SOFTWARE
9.4.1.1
GROWING ADOPTION OF ARTIFICIAL INTELLIGENCE IN PATHOLOGY WORKFLOWS TO ACCELERATE DEMAND FOR AI-INTEGRATED SOFTWARE
9.4.2
NON-AI-INTEGRATED SOFTWARE
9.4.2.1
INCREASING DIGITALIZATION OF PATHOLOGY LABORATORIES TO DRIVE DEMAND FOR NON-AI PATHOLOGY SOFTWARE
9.5.1
GROWING ADOPTION OF DIGITAL PATHOLOGY AND INCREASING DATA VOLUMES TO DRIVE DEMAND FOR PATHOLOGY STORAGE SYSTEMS
10
ANATOMIC PATHOLOGY PRODUCT MARKET, BY PROCESS
Market Size & Growth Rate Forecast Analysis to 2031 in USD Million | 17 Data Tables176
10.2
PREANALYTICS/SAMPLE PREPARATION
10.2.1
GROWING DEMAND FOR EFFICIENT SPECIMEN HANDLING AND LABORATORY AUTOMATION TO DRIVE GROWTH
10.3
ADVANCED STAINING/IHC
10.3.1
GROWING ADOPTION OF MULTIPLEX BIOMARKER ANALYSIS AND AUTOMATED STAINING WORKFLOWS TO SUPPORT MARKET GROWTH
10.4
PRIMARY & SPECIAL STAINING
10.4.1
GROWING DEMAND FOR SPECIALIZED TISSUE & CELLULAR CHARACTERIZATION TO DRIVE GROWTH
10.5.1
GROWING ADOPTION OF WHOLE-SLIDE IMAGING AND AI-ENABLED WORKFLOWS TO DRIVE GROWTH OF DIGITAL PATHOLOGY
11
ANATOMIC PATHOLOGY MARKET, BY DISEASE
Market Size & Growth Rate Forecast Analysis to 2031 in USD Million | 31 Data Tables186
11.2.1
RISING UPTAKE OF HER2 TESTS FOR CANCER DIAGNOSIS TO FUEL MARKET
11.3
NON-SMALL-CELL LUNG CANCER
11.3.1
RISING CASES OF LUNG CANCER TO DRIVE ADOPTION
11.4.1
GROWING RATE OF PROSTATE CANCER TO PROPEL MARKET
11.5.1
RISING INCIDENCE OF GASTROINTESTINAL CANCER TO BOOST MARKET
RISING INCIDENCE OF NON-HODGKIN’S LYMPHOMA IN ADULTS
ANATOMIC PATHOLOGY MARKET VOLUME ANALYSIS,
13
ANATOMIC PATHOLOGY PRODUCT MARKET, BY END USER
Market Size & Growth Rate Forecast Analysis to 2031 in USD Million | 21 Data Tables201
13.2.1
RISING HEALTHCARE INVESTMENT TO CONTRIBUTE TO GROWTH
13.3
RESEARCH LABORATORIES
13.3.1
RISING DEMAND FOR SPECIALTY TESTS TO DRIVE MARKET
13.4
PHARMACEUTICAL COMPANIES
13.4.1
INCREASING R&D ACTIVITIES FOR DISEASE DIAGNOSTICS TO DRIVE MARKET
13.5
CONTRACT RESEARCH ORGANIZATIONS
13.5.1
GROWING DEMAND FOR OUTSOURCING ANALYTICAL TESTING & CLINICAL TRIAL SERVICES TO BOOST MARKET
14
ANATOMIC PATHOLOGY SERVICE MARKET, BY TYPE
Market Size & Growth Rate Forecast Analysis to 2031 in USD Million | 9 Data Tables213
14.2
HISTOPATHOLOGY SERVICES
14.3
CYTOPATHOLOGY SERVICES
15
ANATOMIC PATHOLOGY SERVICE MARKET, BY TYPE
Market Size & Growth Rate Forecast Analysis to 2031 in USD Million | 9 Data Tables218
16
ANATOMIC PATHOLOGY SERVICE MARKET, BY DISEASE
Market Size & Growth Rate Forecast Analysis to 2031 in USD Million | 25 Data Tables223
16.2.1
NON-SMALL CELL LUNG CANCER
16.2.5
OTHER DISEASE TYPE
17
ANATOMIC PATHOLOGY MARKET, BY REGION
Comprehensive coverage of 7 Regions with country-level deep-dive of 10 Countries | 283 Data Tables.234
17.2.1.1
HIGH HEALTHCARE EXPENDITURE TO DRIVE MARKET
17.2.2.1
RISING PREVALENCE OF CANCER TO FUEL MARKET
17.3.1.1
FAVORABLE GOVERNMENT INITIATIVES TO BOOST MARKET
17.3.2.1
RISING INVESTMENTS IN CANCER RESEARCH TO DRIVE MARKET
17.3.3.1
INCREASING DEMAND FOR CANCER DIAGNOSTICS TO PROPEL MARKET
17.3.4.1
HIGH INCIDENCE OF CANCER AND GERIATRIC POPULATION TO SUPPORT GROWTH
17.3.5.1
INCREASED CANCER CASES TO BOOST MARKET
17.4.1.1
INCREASING FOCUS ON HEALTHCARE INFRASTRUCTURE TO BOOST MARKET
17.4.2.1
ESTABLISHED HEALTHCARE SYSTEM TO FUEL MARKET
PRESENCE OF LARGE PATIENT POOL AND RAPIDLY GROWING HEALTHCARE
17.4.4
REST OF ASIA PACIFIC
17.5.1
GROWING ONCOLOGY PATIENT POOL, COMBINED WITH EXPANDING PUBLIC AND PRIVATE INVESTMENTS IN CANCER CARE, TO BOOST GROWTH
17.6
MIDDLE EAST & AFRICA
17.6.1
GOVERNMENT INITIATIVES TO IMPROVE HEALTHCARE INFRASTRUCTURE TO AID ANATOMIC PATHOLOGY MARKET
18
COMPETITIVE LANDSCAPE
Uncover top players' winning strategies and market dominance through 2025's competitive landscape analysis.356
18.2
KEY PLAYER STRATEGIES/RIGHT TO WIN
OVERVIEW OF STRATEGIES DEPLOYED BY PLAYERS IN ANATOMIC
18.3
REVENUE ANALYSIS, 2023–2025
18.4
MARKET SHARE ANALYSIS, 2025
18.4.1
GLOBAL MARKET SHARE ANALYSIS, 2025
18.4.2
US MARKET SHARE ANALYSIS, 2025
18.5
COMPANY EVALUATION MATRIX: KEY PLAYERS, 2025
18.5.5
COMPANY FOOTPRINT: KEY PLAYERS, 2025
18.5.5.1
COMPANY FOOTPRINT
18.5.5.2
REGION FOOTPRINT
18.5.5.4
PROCESS FOOTPRINT
18.5.5.5
END-USER FOOTPRINT
18.6
COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2025
18.6.1
PROGRESSIVE COMPANIES
18.6.2
RESPONSIVE COMPANIES
18.6.5
COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2025
18.6.5.1
DETAILED LIST OF KEY STARTUPS/SMES
18.6.5.2
COMPETITIVE BENCHMARKING OF STARTUPS/SMES (1/2)
18.6.5.3
COMPETITIVE BENCHMARKING OF STARTUPS/SMES (2/2)
18.7
COMPANY VALUATION & FINANCIAL METRICS
18.8
BRAND/PRODUCT COMPARISON
18.9
COMPETITIVE SCENARIO
18.9.1
PRODUCT LAUNCHES & APPROVALS
19
COMPANY PROFILES
In-depth Company Profiles of Leading Market Players with detailed Business Overview, Product and Service Portfolio, Recent Developments, and Unique Analyst Perspective (MnM View)374
19.1.1
F. HOFFMANN-LA ROCHE LTD.
19.1.1.1
BUSINESS OVERVIEW
19.1.1.2
PRODUCTS OFFERED
19.1.1.3
RECENT DEVELOPMENTS
19.1.1.3.1
PRODUCT LAUNCHES & APPROVALS
19.1.1.4.2
STRATEGIC CHOICES
19.1.1.4.3
WEAKNESSES & COMPETITIVE THREATS
19.1.2
DANAHER CORPORATION
19.1.3
PHC HOLDINGS CORPORATION (EPREDIA)
19.1.4
AGILENT TECHNOLOGIES, INC.
19.1.6
BECTON, DICKINSON AND COMPANY (BD)
19.1.7
KONINKLIJKE PHILIPS N.V.
19.1.10
SAKURA FINETEK JAPAN CO., LTD.
19.2.4
HISTO-LINE LABORATORIES
19.2.7
AMOS SCIENTIFIC PTY LTD.
19.2.8
MEDITE MEDICAL GMBH
19.2.9
CELL SIGNALING TECHNOLOGY, INC.
19.2.12
R. K. SCIENTIFIC INSTRUMENT PRIVATE LIMITED
19.2.13
RWD LIFE SCIENCE CO., LTD.
19.2.15
BRIGHT INSTRUMENTS
19.2.16
JINHUA YIDI MEDICAL APPLIANCE CO., LTD.
19.2.17
HAMAMATSU PHOTONICS K.K.
20
RESEARCH METHODOLOGY
439
20.1.1.1
LIST OF SECONDARY SOURCES
20.1.1.2
KEY DATA FROM SECONDARY SOURCES
20.1.2.1
BREAKDOWN OF PRIMARY INTERVIEWS
20.2
MARKET SIZE ESTIMATION
20.2.1
TOTAL MARKET SIZE: ANATOMIC PATHOLOGY MARKET
20.2.2
BOTTOM-UP APPROACH
20.2.2.1
APPROACH 2: STUDY OF ANNUAL REPORTS AND INVESTOR PRESENTATIONS
20.2.2.2
APPROACH 3: PRIMARY INTERVIEWS
20.4
RESEARCH ASSUMPTIONS
20.4.1
STUDY-RELATED ASSUMPTIONS
20.5.1
PARAMETRIC ASSUMPTIONS
20.5.2
GROWTH RATE ASSUMPTIONS
20.6
RESEARCH LIMITATIONS
21.2
KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
21.3
CUSTOMIZATION OPTIONS
INCREASING INCIDENCE OF CANCER, BY REGION,
2024
VS. 2030 VS. 2040 (MILLION)
58
PROJECTED INCREASE IN GLOBAL NUMBER OF CANCER PATIENTS,
2024
VS. 2030 VS. 2040 (MILLION)
58
TABLE 3
% OF PERSONALIZED MEDICINES IN OVERALL DRUG APPROVAL BY FDA, 2015–2024
TABLE 4
ANATOMIC PATHOLOGY MARKET: PORTER’S FIVE FORCES ANALYSIS
TABLE 5
GDP PERCENTAGE CHANGE (%), BY KEY COUNTRY, 2023–2030
TABLE 6
NORTH AMERICA: MACROECONOMIC INDICATORS
TABLE 7
EUROPE: MACROECONOMIC INDICATORS
TABLE 8
ASIA PACIFIC: MACROECONOMIC INDICATORS
TABLE 9
LATIN AMERICA: MACROECONOMIC INDICATORS
TABLE 10
MIDDLE EAST & AFRICA: MACROECONOMIC INDICATORS
TABLE 11
AVERAGE SELLING PRICE OF ANATOMIC PATHOLOGY PRODUCTS, BY KEY PLAYER, 2024–2026 (USD)
TABLE 12
AVERAGE SELLING PRICE OF ANATOMIC PATHOLOGY PRODUCTS, BY REGION, 2024–2026 (USD)
TABLE 13
IMPORT DATA FOR HS CODE 3822-COMPLIANT PRODUCTS, BY COUNTRY, 2021–2025 (USD MILLION)
TABLE 14
EXPORT DATA FOR HS CODE 3822-COMPLIANT PRODUCTS, BY COUNTRY, 2021–2025 (USD MILLION)
TABLE 15
ANATOMIC PATHOLOGY MARKET: KEY CONFERENCES & EVENTS, 2026–2027
TABLE 16
US-ADJUSTED RECIPROCAL TARIFF RATES
TABLE 17
KEY PATENTS IN ANATOMIC PATHOLOGY MARKET, 2022–2026
TABLE 18
KEY COMPANIES IMPLEMENTING AI IN ANATOMIC PATHOLOGY MARKET
TABLE 19
CLASSIFICATION OF IVD DEVICES IN EUROPE
TABLE 20
TIME, COST, AND COMPLEXITY OF REGISTRATION PROCESS IN JAPAN
TABLE 21
NORTH AMERICA: KEY REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 22
EUROPE: KEY REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 23
ASIA PACIFIC: KEY REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 24
LATIN AMERICA: KEY REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 25
REST OF THE WORLD: KEY REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 26
INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS, BY END USER (%)
TABLE 27
KEY BUYING CRITERIA, BY END USER
TABLE 28
ADOPTION BARRIERS & INTERNAL CHALLENGES
TABLE 29
ANATOMIC PATHOLOGY MARKET: UNMET NEEDS IN VARIOUS END-USE INDUSTRIES
TABLE 30
ANATOMIC PATHOLOGY PRODUCT MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 31
ANATOMIC PATHOLOGY PRODUCT MARKET FOR CONSUMABLES, BY TYPE, 2024–2031 (USD MILLION)
TABLE 32
ANATOMIC PATHOLOGY PRODUCT MARKET FOR HISTOPATHOLOGY CONSUMABLES, BY TYPE, 2024–2031 (USD MILLION)
TABLE 33
ANATOMIC PATHOLOGY PRODUCT MARKET FOR HISTOPATHOLOGY CONSUMABLES, BY REGION, 2024–2031 (USD MILLION)
TABLE 34
NORTH AMERICA: ANATOMIC PATHOLOGY PRODUCT MARKET FOR HISTOPATHOLOGY CONSUMABLES, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 35
EUROPE: ANATOMIC PATHOLOGY PRODUCT MARKET FOR HISTOPATHOLOGY CONSUMABLES, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 36
ASIA PACIFIC: ANATOMIC PATHOLOGY PRODUCT MARKET FOR HISTOPATHOLOGY CONSUMABLES, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 37
ANATOMIC PATHOLOGY PRODUCT MARKET FOR HISTOPATHOLOGY ANTIBODIES, BY TYPE, 2024–2031 (USD MILLION)
TABLE 38
ANATOMIC PATHOLOGY PRODUCT MARKET FOR HISTOPATHOLOGY ANTIBODIES, BY REGION, 2024–2031 (USD MILLION)
TABLE 39
NORTH AMERICA: ANATOMIC PATHOLOGY PRODUCT MARKET FOR HISTOPATHOLOGY ANTIBODIES, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 40
EUROPE: ANATOMIC PATHOLOGY PRODUCT MARKET FOR HISTOPATHOLOGY ANTIBODIES, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 41
ASIA PACIFIC: ANATOMIC PATHOLOGY PRODUCT MARKET FOR HISTOPATHOLOGY ANTIBODIES, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 42
PRIMARY HISTOPATHOLOGY ANTIBODIES AVAILABLE IN MARKET
TABLE 43
ANATOMIC PATHOLOGY PRODUCT MARKET FOR PRIMARY HISTOPATHOLOGY ANTIBODIES, BY REGION, 2024–2031 (USD MILLION)
TABLE 44
NORTH AMERICA: ANATOMIC PATHOLOGY PRODUCT MARKET FOR PRIMARY HISTOPATHOLOGY ANTIBODIES, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 45
EUROPE: ANATOMIC PATHOLOGY PRODUCT MARKET FOR PRIMARY HISTOPATHOLOGY ANTIBODIES, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 46
ASIA PACIFIC: ANATOMIC PATHOLOGY PRODUCT MARKET FOR PRIMARY HISTOPATHOLOGY ANTIBODIES, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 47
ANATOMIC PATHOLOGY PRODUCT MARKET FOR SECONDARY HISTOPATHOLOGY ANTIBODIES, BY REGION, 2024–2031 (USD MILLION)
TABLE 48
NORTH AMERICA: ANATOMIC PATHOLOGY PRODUCT MARKET FOR SECONDARY HISTOPATHOLOGY ANTIBODIES, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 49
EUROPE: ANATOMIC PATHOLOGY PRODUCT MARKET FOR SECONDARY HISTOPATHOLOGY ANTIBODIES, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 50
ASIA PACIFIC: ANATOMIC PATHOLOGY PRODUCT MARKET FOR SECONDARY HISTOPATHOLOGY ANTIBODIES, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 51
ANATOMIC PATHOLOGY PRODUCT MARKET FOR HISTOPATHOLOGY KITS & REAGENTS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 52
ANATOMIC PATHOLOGY PRODUCT MARKET FOR HISTOPATHOLOGY KITS & REAGENTS, BY REGION, 2024–2031 (USD MILLION)
TABLE 53
NORTH AMERICA: ANATOMIC PATHOLOGY PRODUCT MARKET FOR HISTOPATHOLOGY KITS & REAGENTS, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 54
EUROPE: ANATOMIC PATHOLOGY PRODUCT MARKET FOR HISTOPATHOLOGY KITS & REAGENTS, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 55
ASIA PACIFIC: ANATOMIC PATHOLOGY PRODUCT MARKET FOR HISTOPATHOLOGY KITS & REAGENTS, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 56
ANATOMIC PATHOLOGY PRODUCT MARKET FOR HISTOPATHOLOGY STAINS & SOLVENTS, BY REGION, 2024–2031 (USD MILLION)
TABLE 57
NORTH AMERICA: ANATOMIC PATHOLOGY PRODUCT MARKET FOR HISTOPATHOLOGY STAINS & SOLVENTS, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 58
EUROPE: ANATOMIC PATHOLOGY PRODUCT MARKET FOR HISTOPATHOLOGY STAINS & SOLVENTS, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 59
ASIA PACIFIC: ANATOMIC PATHOLOGY PRODUCT MARKET FOR HISTOPATHOLOGY STAINS & SOLVENTS, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 60
ANATOMIC PATHOLOGY PRODUCT MARKET FOR HISTOPATHOLOGY FIXATIVES, BY REGION, 2024–2031 (USD MILLION)
TABLE 61
NORTH AMERICA: ANATOMIC PATHOLOGY PRODUCT MARKET FOR HISTOPATHOLOGY FIXATIVES, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 62
EUROPE: ANATOMIC PATHOLOGY PRODUCT MARKET FOR HISTOPATHOLOGY FIXATIVES, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 63
ASIA PACIFIC: ANATOMIC PATHOLOGY PRODUCT MARKET FOR HISTOPATHOLOGY FIXATIVES, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 64
ANATOMIC PATHOLOGY PRODUCT MARKET FOR OTHER HISTOPATHOLOGY KITS & REAGENTS, BY REGION, 2024–2031 (USD MILLION)
TABLE 65
NORTH AMERICA: ANATOMIC PATHOLOGY PRODUCT MARKET FOR OTHER HISTOPATHOLOGY KITS & REAGENTS, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 66
EUROPE: ANATOMIC PATHOLOGY PRODUCT MARKET FOR OTHER HISTOPATHOLOGY KITS & REAGENTS, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 67
ASIA PACIFIC: ANATOMIC PATHOLOGY PRODUCT MARKET FOR OTHER HISTOPATHOLOGY KITS & REAGENTS, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 68
HISTOPATHOLOGY PROBES AVAILABLE IN MARKET
TABLE 69
ANATOMIC PATHOLOGY PRODUCT MARKET FOR HISTOPATHOLOGY PROBES, BY REGION, 2024–2031 (USD MILLION)
TABLE 70
NORTH AMERICA: ANATOMIC PATHOLOGY PRODUCT MARKET FOR HISTOPATHOLOGY PROBES, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 71
EUROPE: ANATOMIC PATHOLOGY PRODUCT MARKET FOR HISTOPATHOLOGY PROBES, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 72
ASIA PACIFIC: ANATOMIC PATHOLOGY PRODUCT MARKET FOR HISTOPATHOLOGY PROBES, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 73
ANATOMIC PATHOLOGY PRODUCT MARKET FOR OTHER HISTOPATHOLOGY CONSUMABLES, BY REGION, 2024–2031 (USD MILLION)
TABLE 74
NORTH AMERICA: ANATOMIC PATHOLOGY PRODUCT MARKET FOR OTHER HISTOPATHOLOGY CONSUMABLES, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 75
EUROPE: ANATOMIC PATHOLOGY PRODUCT MARKET FOR OTHER HISTOPATHOLOGY CONSUMABLES, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 76
ASIA PACIFIC: ANATOMIC PATHOLOGY PRODUCT MARKET FOR OTHER HISTOPATHOLOGY CONSUMABLES, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 77
ANATOMIC PATHOLOGY PRODUCT MARKET FOR CYTOPATHOLOGY CONSUMABLES, BY TYPE, 2024–2031 (USD MILLION)
TABLE 78
ANATOMIC PATHOLOGY PRODUCT MARKET FOR CYTOPATHOLOGY CONSUMABLES, BY REGION, 2024–2031 (USD MILLION)
TABLE 79
NORTH AMERICA: ANATOMIC PATHOLOGY PRODUCT MARKET FOR CYTOPATHOLOGY CONSUMABLES, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 80
EUROPE: ANATOMIC PATHOLOGY PRODUCT MARKET FOR CYTOPATHOLOGY CONSUMABLES, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 81
ASIA PACIFIC: ANATOMIC PATHOLOGY PRODUCT MARKET FOR CYTOPATHOLOGY CONSUMABLES, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 82
ANATOMIC PATHOLOGY PRODUCT MARKET FOR CYTOPATHOLOGY ANTIBODIES, BY TYPE, 2024–2031 (USD MILLION)
TABLE 83
ANATOMIC PATHOLOGY PRODUCT MARKET FOR CYTOPATHOLOGY ANTIBODIES, BY REGION, 2024–2031 (USD MILLION)
TABLE 84
NORTH AMERICA: ANATOMIC PATHOLOGY PRODUCT MARKET FOR CYTOPATHOLOGY ANTIBODIES, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 85
EUROPE: ANATOMIC PATHOLOGY PRODUCT MARKET FOR CYTOPATHOLOGY ANTIBODIES, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 86
ASIA PACIFIC: ANATOMIC PATHOLOGY PRODUCT MARKET FOR CYTOPATHOLOGY ANTIBODIES, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 87
PRIMARY CYTOPATHOLOGY ANTIBODIES AVAILABLE IN MARKET
TABLE 88
ANATOMIC PATHOLOGY PRODUCT MARKET FOR PRIMARY CYTOPATHOLOGY ANTIBODIES, BY REGION, 2024–2031 (USD MILLION)
TABLE 89
NORTH AMERICA: ANATOMIC PATHOLOGY PRODUCT MARKET FOR PRIMARY CYTOPATHOLOGY ANTIBODIES, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 90
EUROPE: ANATOMIC PATHOLOGY PRODUCT MARKET FOR PRIMARY CYTOPATHOLOGY ANTIBODIES, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 91
ASIA PACIFIC: ANATOMIC PATHOLOGY PRODUCT MARKET FOR PRIMARY CYTOPATHOLOGY ANTIBODIES, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 92
ANATOMIC PATHOLOGY PRODUCT MARKET FOR SECONDARY CYTOPATHOLOGY ANTIBODIES, BY REGION, 2024–2031 (USD MILLION)
TABLE 93
NORTH AMERICA: ANATOMIC PATHOLOGY PRODUCT MARKET FOR SECONDARY CYTOPATHOLOGY ANTIBODIES, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 94
EUROPE: ANATOMIC PATHOLOGY PRODUCT MARKET FOR SECONDARY CYTOPATHOLOGY ANTIBODIES, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 95
ASIA PACIFIC: ANATOMIC PATHOLOGY PRODUCT MARKET FOR SECONDARY CYTOPATHOLOGY ANTIBODIES, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 96
ANATOMIC PATHOLOGY PRODUCT MARKET FOR CYTOPATHOLOGY KITS & REAGENTS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 97
ANATOMIC PATHOLOGY PRODUCT MARKET FOR CYTOPATHOLOGY KITS & REAGENTS, BY REGION, 2024–2031 (USD MILLION)
TABLE 98
NORTH AMERICA: ANATOMIC PATHOLOGY PRODUCT MARKET FOR CYTOPATHOLOGY KITS & REAGENTS, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 99
EUROPE: ANATOMIC PATHOLOGY PRODUCT MARKET FOR CYTOPATHOLOGY KITS & REAGENTS, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 100
ASIA PACIFIC: ANATOMIC PATHOLOGY PRODUCT MARKET FOR CYTOPATHOLOGY KITS & REAGENTS, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 101
ANATOMIC PATHOLOGY PRODUCT MARKET FOR CYTOPATHOLOGY STAINS & SOLVENTS, BY REGION, 2024–2031 (USD MILLION)
TABLE 102
NORTH AMERICA: ANATOMIC PATHOLOGY PRODUCT MARKET FOR CYTOPATHOLOGY STAINS & SOLVENTS, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 103
EUROPE: ANATOMIC PATHOLOGY PRODUCT MARKET FOR CYTOPATHOLOGY STAINS & SOLVENTS, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 104
ASIA PACIFIC: ANATOMIC PATHOLOGY PRODUCT MARKET FOR CYTOPATHOLOGY STAINS & SOLVENTS, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 105
ANATOMIC PATHOLOGY PRODUCT MARKET FOR CYTOPATHOLOGY FIXATIVES, BY REGION, 2024–2031 (USD MILLION)
TABLE 106
NORTH AMERICA: ANATOMIC PATHOLOGY PRODUCT MARKET FOR CYTOPATHOLOGY FIXATIVES, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 107
EUROPE: ANATOMIC PATHOLOGY PRODUCT MARKET FOR CYTOPATHOLOGY FIXATIVES, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 108
ASIA PACIFIC: ANATOMIC PATHOLOGY PRODUCT MARKET FOR CYTOPATHOLOGY FIXATIVES, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 109
ANATOMIC PATHOLOGY PRODUCT MARKET FOR OTHER CYTOPATHOLOGY KITS & REAGENTS, BY REGION, 2024–2031 (USD MILLION)
TABLE 110
NORTH AMERICA: ANATOMIC PATHOLOGY PRODUCT MARKET FOR OTHER CYTOPATHOLOGY KITS & REAGENTS, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 111
EUROPE: ANATOMIC PATHOLOGY PRODUCT MARKET FOR OTHER CYTOPATHOLOGY KITS & REAGENTS, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 112
ASIA PACIFIC: ANATOMIC PATHOLOGY PRODUCT MARKET FOR OTHER CYTOPATHOLOGY KITS & REAGENTS, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 113
ANATOMIC PATHOLOGY PRODUCT MARKET FOR CYTOPATHOLOGY PROBES, BY REGION, 2024–2031 (USD MILLION)
TABLE 114
NORTH AMERICA: ANATOMIC PATHOLOGY PRODUCT MARKET FOR CYTOPATHOLOGY PROBES, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 115
EUROPE: ANATOMIC PATHOLOGY PRODUCT MARKET FOR CYTOPATHOLOGY PROBES, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 116
ASIA PACIFIC: ANATOMIC PATHOLOGY PRODUCT MARKET FOR CYTOPATHOLOGY PROBES, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 117
ANATOMIC PATHOLOGY PRODUCT MARKET FOR OTHER CYTOPATHOLOGY CONSUMABLES, BY REGION, 2024–2031 (USD MILLION)
TABLE 118
NORTH AMERICA: ANATOMIC PATHOLOGY PRODUCT MARKET FOR OTHER CYTOPATHOLOGY CONSUMABLES, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 119
EUROPE: ANATOMIC PATHOLOGY PRODUCT MARKET FOR OTHER CYTOPATHOLOGY CONSUMABLES, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 120
ASIA PACIFIC: ANATOMIC PATHOLOGY PRODUCT MARKET FOR OTHER CYTOPATHOLOGY CONSUMABLES, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 121
ANATOMIC PATHOLOGY PRODUCT MARKET FOR INSTRUMENTS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 122
KEY SLIDE STAINING SYSTEMS AVAILABLE IN MARKET
TABLE 123
ANATOMIC PATHOLOGY PRODUCT MARKET FOR SLIDE STAINING SYSTEMS, BY REGION, 2024–2031 (USD MILLION)
TABLE 124
NORTH AMERICA: ANATOMIC PATHOLOGY PRODUCT MARKET FOR SLIDE STAINING SYSTEMS, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 125
EUROPE: ANATOMIC PATHOLOGY PRODUCT MARKET FOR SLIDE STAINING SYSTEMS, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 126
ASIA PACIFIC: ANATOMIC PATHOLOGY PRODUCT MARKET FOR SLIDE STAINING SYSTEMS, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 127
KEY TISSUE PROCESSING SYSTEMS AVAILABLE IN MARKET
TABLE 128
ANATOMIC PATHOLOGY PRODUCT MARKET FOR TISSUE PROCESSING SYSTEMS, BY REGION, 2024–2031 (USD MILLION)
TABLE 129
NORTH AMERICA: ANATOMIC PATHOLOGY PRODUCT MARKET FOR TISSUE PROCESSING SYSTEMS, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 130
EUROPE: ANATOMIC PATHOLOGY PRODUCT MARKET FOR TISSUE PROCESSING SYSTEMS, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 131
ASIA PACIFIC: ANATOMIC PATHOLOGY PRODUCT MARKET FOR TISSUE PROCESSING SYSTEMS, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 132
ANATOMIC PATHOLOGY PRODUCT MARKET FOR CELL PROCESSORS, BY REGION, 2024–2031 (USD MILLION)
TABLE 133
NORTH AMERICA: ANATOMIC PATHOLOGY PRODUCT MARKET FOR CELL PROCESSORS, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 134
EUROPE: ANATOMIC PATHOLOGY PRODUCT MARKET FOR CELL PROCESSORS, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 135
ASIA PACIFIC: ANATOMIC PATHOLOGY PRODUCT MARKET FOR CELL PROCESSORS, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 136
MICROTOMES AVAILABLE IN MARKET
TABLE 137
ANATOMIC PATHOLOGY PRODUCT MARKET FOR MICROTOMES, BY REGION, 2024–2031 (USD MILLION)
TABLE 138
NORTH AMERICA: ANATOMIC PATHOLOGY PRODUCT MARKET FOR MICROTOMES, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 139
EUROPE: ANATOMIC PATHOLOGY PRODUCT MARKET FOR MICROTOMES, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 140
ASIA PACIFIC: ANATOMIC PATHOLOGY PRODUCT MARKET FOR MICROTOMES, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 141
ANATOMIC PATHOLOGY PRODUCT MARKET FOR EMBEDDING SYSTEMS, BY REGION, 2024–2031 (USD MILLION)
TABLE 142
NORTH AMERICA: ANATOMIC PATHOLOGY PRODUCT MARKET FOR EMBEDDING SYSTEMS, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 143
EUROPE: ANATOMIC PATHOLOGY PRODUCT MARKET FOR EMBEDDING SYSTEMS, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 144
ASIA PACIFIC: ANATOMIC PATHOLOGY PRODUCT MARKET FOR EMBEDDING SYSTEMS, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 145
ANATOMIC PATHOLOGY PRODUCT MARKET FOR COVERSLIPPERS, BY REGION, 2024–2031 (USD MILLION)
TABLE 146
NORTH AMERICA: ANATOMIC PATHOLOGY PRODUCT MARKET FOR COVERSLIPPERS, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 147
EUROPE: ANATOMIC PATHOLOGY PRODUCT MARKET FOR COVERSLIPPERS, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 148
ASIA PACIFIC: ANATOMIC PATHOLOGY PRODUCT MARKET FOR COVERSLIPPERS, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 149
DIGITAL PATHOLOGY SCANNERS AVAILABLE IN MARKET
TABLE 150
ANATOMIC PATHOLOGY PRODUCT MARKET FOR DIGITAL PATHOLOGY SCANNERS, BY REGION, 2024–2031 (USD MILLION)
TABLE 151
NORTH AMERICA: ANATOMIC PATHOLOGY PRODUCT MARKET FOR DIGITAL PATHOLOGY SCANNERS, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 152
EUROPE: ANATOMIC PATHOLOGY PRODUCT MARKET FOR DIGITAL PATHOLOGY SCANNERS, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 153
ASIA PACIFIC: ANATOMIC PATHOLOGY PRODUCT MARKET FOR DIGITAL PATHOLOGY SCANNERS, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 154
ANATOMIC PATHOLOGY PRODUCT MARKET FOR OTHER INSTRUMENTS, BY REGION, 2024–2031 (USD MILLION)
TABLE 155
NORTH AMERICA: ANATOMIC PATHOLOGY PRODUCT MARKET FOR OTHER INSTRUMENTS, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 156
EUROPE: ANATOMIC PATHOLOGY PRODUCT MARKET FOR OTHER INSTRUMENTS, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 157
ASIA PACIFIC: ANATOMIC PATHOLOGY PRODUCT MARKET FOR OTHER INSTRUMENTS, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 158
SOFTWARE AVAILABLE IN MARKET
TABLE 159
ANATOMIC PATHOLOGY PRODUCT MARKET FOR SOFTWARE, BY TYPE, 2024–2031 (USD MILLION)
TABLE 160
ANATOMIC PATHOLOGY PRODUCT MARKET FOR AI-INTEGRATED SOFTWARE, BY REGION, 2024–2031 (USD MILLION)
TABLE 161
NORTH AMERICA: ANATOMIC PATHOLOGY PRODUCT MARKET FOR AI-INTEGRATED SOFTWARE, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 162
EUROPE: ANATOMIC PATHOLOGY PRODUCT MARKET FOR AI-INTEGRATED SOFTWARE, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 163
ASIA PACIFIC: ANATOMIC PATHOLOGY PRODUCT MARKET FOR AI-INTEGRATED SOFTWARE, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 164
ANATOMIC PATHOLOGY PRODUCT MARKET FOR NON-AI-INTEGRATED SOFTWARE, BY REGION, 2024–2031 (USD MILLION)
TABLE 165
NORTH AMERICA: ANATOMIC PATHOLOGY PRODUCT MARKET FOR NON-AI-INTEGRATED SOFTWARE, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 166
EUROPE: ANATOMIC PATHOLOGY PRODUCT MARKET FOR NON-AI-INTEGRATED SOFTWARE, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 167
ASIA PACIFIC: ANATOMIC PATHOLOGY PRODUCT MARKET FOR NON-AI-INTEGRATED SOFTWARE, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 168
ANATOMIC PATHOLOGY PRODUCT MARKET FOR STORAGE SYSTEMS, BY REGION, 2024–2031 (USD MILLION)
TABLE 169
NORTH AMERICA: ANATOMIC PATHOLOGY PRODUCT MARKET FOR STORAGE SYSTEMS, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 170
EUROPE: ANATOMIC PATHOLOGY PRODUCT MARKET FOR STORAGE SYSTEMS, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 171
ASIA PACIFIC: ANATOMIC PATHOLOGY PRODUCT MARKET FOR STORAGE SYSTEMS, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 172
ANATOMIC PATHOLOGY PRODUCT MARKET, BY PROCESS, 2024–2031 (USD MILLION)
TABLE 173
ANATOMIC PATHOLOGY PRODUCT MARKET FOR PREANALYTICS/SAMPLE PREPARATION, BY REGION, 2024–2031 (USD MILLION)
TABLE 174
NORTH AMERICA: ANATOMIC PATHOLOGY PRODUCT MARKET FOR PREANALYTICS/SAMPLE PREPARATION, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 175
EUROPE: ANATOMIC PATHOLOGY PRODUCT MARKET FOR PREANALYTICS/SAMPLE PREPARATION, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 176
ASIA PACIFIC: ANATOMIC PATHOLOGY PRODUCT MARKET FOR PREANALYTICS/SAMPLE PREPARATION, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 177
ANATOMIC PATHOLOGY PRODUCT MARKET FOR ADVANCED STAINING/IHC, BY REGION, 2024–2031 (USD MILLION)
TABLE 178
NORTH AMERICA: ANATOMIC PATHOLOGY PRODUCT MARKET FOR ADVANCED STAINING/IHC, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 179
EUROPE: ANATOMIC PATHOLOGY PRODUCT MARKET FOR ADVANCED STAINING/IHC, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 180
ASIA PACIFIC: ANATOMIC PATHOLOGY PRODUCT MARKET FOR ADVANCED STAINING/IHC, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 181
ANATOMIC PATHOLOGY PRODUCT MARKET FOR PRIMARY & SPECIAL STAINING, BY REGION, 2024–2031 (USD MILLION)
TABLE 182
NORTH AMERICA: ANATOMIC PATHOLOGY PRODUCT MARKET FOR PRIMARY & SPECIAL STAINING, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 183
EUROPE: ANATOMIC PATHOLOGY PRODUCT MARKET FOR PRIMARY & SPECIAL STAINING, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 184
ASIA PACIFIC: ANATOMIC PATHOLOGY PRODUCT MARKET FOR PRIMARY & SPECIAL STAINING, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 185
ANATOMIC PATHOLOGY PRODUCT MARKET FOR DIGITAL PATHOLOGY, BY REGION, 2024–2031 (USD MILLION)
TABLE 186
NORTH AMERICA: ANATOMIC PATHOLOGY PRODUCT MARKET FOR DIGITAL PATHOLOGY, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 187
EUROPE: ANATOMIC PATHOLOGY PRODUCT MARKET FOR DIGITAL PATHOLOGY, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 188
ASIA PACIFIC: ANATOMIC PATHOLOGY PRODUCT MARKET FOR DIGITAL PATHOLOGY, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 189
GLOBAL CANCER INCIDENCE, 2022 VS. 2040
TABLE 190
ANATOMIC PATHOLOGY PRODUCT MARKET, BY DISEASE, 2024–2031 (USD MILLION)
TABLE 191
BREAST CANCER INCIDENCE, BY REGION, 2024 VS. 2050
TABLE 192
ANATOMIC PATHOLOGY PRODUCT MARKET FOR BREAST CANCER, BY REGION, 2024–2031 (USD MILLION)
TABLE 193
NORTH AMERICA: ANATOMIC PATHOLOGY PRODUCT MARKET FOR BREAST CANCER, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 194
EUROPE: ANATOMIC PATHOLOGY PRODUCT MARKET FOR BREAST CANCER, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 195
ASIA PACIFIC: ANATOMIC PATHOLOGY PRODUCT MARKET FOR BREAST CANCER, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 196
ANATOMIC PATHOLOGY PRODUCT MARKET FOR NON-SMALL-CELL LUNG CANCER, BY REGION, 2024–2031 (USD MILLION)
TABLE 197
NORTH AMERICA: ANATOMIC PATHOLOGY PRODUCT MARKET FOR NON-SMALL-CELL LUNG CANCER, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 198
EUROPE: ANATOMIC PATHOLOGY PRODUCT MARKET FOR NON-SMALL-CELL LUNG CANCER, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 199
ASIA PACIFIC: ANATOMIC PATHOLOGY PRODUCT MARKET FOR NON-SMALL-CELL LUNG CANCER, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 200
PROSTATE CANCER INCIDENCE, BY REGION, 2024 VS. 2050
TABLE 201
ANATOMIC PATHOLOGY PRODUCT MARKET FOR PROSTATE CANCER, BY REGION, 2024–2031 (USD MILLION)
TABLE 202
NORTH AMERICA: ANATOMIC PATHOLOGY PRODUCT MARKET FOR PROSTATE CANCER, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 203
EUROPE: ANATOMIC PATHOLOGY PRODUCT MARKET FOR PROSTATE CANCER, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 204
ASIA PACIFIC: ANATOMIC PATHOLOGY PRODUCT MARKET FOR PROSTATE CANCER, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 205
ANATOMIC PATHOLOGY PRODUCT MARKET FOR GASTRIC CANCER, BY, BY REGION, 2024–2031 (USD MILLION)
TABLE 206
NORTH AMERICA: ANATOMIC PATHOLOGY PRODUCT MARKET FOR GASTRIC CANCER, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 207
EUROPE: ANATOMIC PATHOLOGY PRODUCT MARKET FOR GASTRIC CANCER, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 208
ASIA PACIFIC: ANATOMIC PATHOLOGY PRODUCT MARKET FOR GASTRIC CANCER, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 209
HODGKIN LYMPHOMA INCIDENCE, BY REGION, 2024 VS. 2050
TABLE 210
NON-HODGKIN LYMPHOMA INCIDENCE, BY REGION, 2024 VS. 2050
TABLE 211
ANATOMIC PATHOLOGY PRODUCT MARKET FOR LYMPHOMA, BY REGION, 2024–2031 (USD MILLION)
TABLE 212
NORTH AMERICA: ANATOMIC PATHOLOGY PRODUCT MARKET FOR LYMPHOMA, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 213
EUROPE: ANATOMIC PATHOLOGY PRODUCT MARKET FOR LYMPHOMA, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 214
ASIA PACIFIC: ANATOMIC PATHOLOGY PRODUCT MARKET FOR LYMPHOMA, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 215
ANATOMIC PATHOLOGY PRODUCT MARKET FOR OTHER DISEASES, BY REGION, 2024–2031 (USD MILLION)
TABLE 216
NORTH AMERICA: ANATOMIC PATHOLOGY PRODUCT MARKET FOR OTHER DISEASES, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 217
EUROPE: ANATOMIC PATHOLOGY PRODUCT MARKET FOR OTHER DISEASES, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 218
ASIA PACIFIC: ANATOMIC PATHOLOGY PRODUCT MARKET FOR OTHER DISEASES, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 219
ANATOMIC PATHOLOGY MARKET, BY DISEASE, 2024–2031 (NO. OF TESTS)
TABLE 220
ANATOMIC PATHOLOGY PRODUCT MARKET, BY END USER, 2024–2031 (USD MILLION)
TABLE 221
ANATOMIC PATHOLOGY PRODUCT MARKET FOR HOSPITALS, BY REGION, 2024–2031 (USD MILLION)
TABLE 222
NORTH AMERICA: ANATOMIC PATHOLOGY PRODUCT MARKET FOR HOSPITALS, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 223
EUROPE: ANATOMIC PATHOLOGY PRODUCT MARKET FOR HOSPITALS, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 224
ASIA PACIFIC: ANATOMIC PATHOLOGY PRODUCT MARKET FOR HOSPITALS, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 225
ANATOMIC PATHOLOGY PRODUCT MARKET FOR RESEARCH LABORATORIES, BY REGION, 2024–2031 (USD MILLION)
TABLE 226
NORTH AMERICA: ANATOMIC PATHOLOGY PRODUCT MARKET FOR RESEARCH LABORATORIES, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 227
EUROPE: ANATOMIC PATHOLOGY PRODUCT MARKET FOR RESEARCH LABORATORIES, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 228
ASIA PACIFIC: ANATOMIC PATHOLOGY PRODUCT MARKET FOR RESEARCH LABORATORIES, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 229
ANATOMIC PATHOLOGY PRODUCT MARKET FOR PHARMACEUTICAL COMPANIES, BY REGION, 2024–2031 (USD MILLION)
TABLE 230
NORTH AMERICA: ANATOMIC PATHOLOGY PRODUCT MARKET FOR PHARMACEUTICAL COMPANIES, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 231
EUROPE: ANATOMIC PATHOLOGY PRODUCT MARKET FOR PHARMACEUTICAL COMPANIES, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 232
ASIA PACIFIC: ANATOMIC PATHOLOGY PRODUCT MARKET FOR PHARMACEUTICAL COMPANIES, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 233
ANATOMIC PATHOLOGY PRODUCT MARKET FOR CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2024–2031 (USD MILLION)
TABLE 234
NORTH AMERICA: ANATOMIC PATHOLOGY PRODUCT MARKET FOR CONTRACT RESEARCH ORGANIZATIONS, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 235
EUROPE: ANATOMIC PATHOLOGY PRODUCT MARKET FOR CONTRACT RESEARCH ORGANIZATIONS, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 236
ASIA PACIFIC: ANATOMIC PATHOLOGY PRODUCT MARKET FOR CONTRACT RESEARCH ORGANIZATIONS, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 237
ANATOMIC PATHOLOGY PRODUCT MARKET FOR OTHER END USERS, BY REGION, 2024–2031 (USD MILLION)
TABLE 238
NORTH AMERICA: ANATOMIC PATHOLOGY PRODUCT MARKET FOR OTHER END USERS, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 239
EUROPE: ANATOMIC PATHOLOGY PRODUCT MARKET FOR OTHER END USERS, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 240
ASIA PACIFIC: ANATOMIC PATHOLOGY PRODUCT MARKET FOR OTHER END USERS, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 241
ANATOMIC PATHOLOGY SERVICE MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 242
ANATOMIC PATHOLOGY SERVICE MARKET FOR HISTOPATHOLOGY SERVICES, BY REGION, 2024–2031 (USD MILLION)
TABLE 243
NORTH AMERICA: ANATOMIC PATHOLOGY SERVICE MARKET FOR HISTOPATHOLOGY SERVICES, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 244
EUROPE: ANATOMIC PATHOLOGY SERVICE MARKET FOR HISTOPATHOLOGY SERVICES, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 245
ASIA PACIFIC: ANATOMIC PATHOLOGY SERVICES MARKET FOR HISTOPATHOLOGY SERVICES, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 246
ANATOMIC PATHOLOGY SERVICE MARKET FOR CYTOPATHOLOGY SERVICES, BY REGION, 2024–2031 (USD MILLION)
TABLE 247
NORTH AMERICA: ANATOMIC PATHOLOGY SERVICE MARKET FOR CYTOPATHOLOGY SERVICES, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 248
EUROPE: ANATOMIC PATHOLOGY SERVICE MARKET FOR CYTOPATHOLOGY SERVICES, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 249
ASIA PACIFIC: ANATOMIC PATHOLOGY SERVICE MARKET FOR CYTOPATHOLOGY SERVICES, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 250
ANATOMIC PATHOLOGY SERVICE MARKET, BY MODEL, 2024–2031 (USD MILLION)
TABLE 251
ANATOMIC PATHOLOGY SERVICE MARKET FOR IN-HOUSE, BY REGION, 2024–2031 (USD MILLION)
TABLE 252
NORTH AMERICA: ANATOMIC PATHOLOGY SERVICE MARKET FOR IN-HOUSE, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 253
EUROPE: ANATOMIC PATHOLOGY SERVICE MARKET FOR IN-HOUSE, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 254
ASIA PACIFIC: ANATOMIC PATHOLOGY SERVICE MARKET FOR IN-HOUSE, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 255
ANATOMIC PATHOLOGY SERVICE MARKET FOR OUTSOURCED, BY REGION, 2024–2031 (USD MILLION)
TABLE 256
NORTH AMERICA: ANATOMIC PATHOLOGY SERVICE MARKET FOR OUTSOURCED, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 257
EUROPE: ANATOMIC PATHOLOGY SERVICE MARKET FOR OUTSOURCED, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 258
ASIA PACIFIC: ANATOMIC PATHOLOGY SERVICE MARKET FOR OUTSOURCED, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 259
ANATOMIC PATHOLOGY SERVICE MARKET, BY DISEASE, 2024–2031 (USD MILLION)
TABLE 260
ANATOMIC PATHOLOGY SERVICE MARKET FOR BREAST CANCER, BY REGION, 2024–2031 (USD MILLION)
TABLE 261
NORTH AMERICA: ANATOMIC PATHOLOGY SERVICE MARKET FOR BREAST CANCER, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 262
EUROPE: ANATOMIC PATHOLOGY SERVICE MARKET FOR BREAST CANCER, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 263
ASIA PACIFIC: ANATOMIC PATHOLOGY SERVICE MARKET FOR BREAST CANCER, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 264
ANATOMIC PATHOLOGY SERVICE MARKET FOR NON-SMALL CELL LUNG CANCER, BY REGION, 2024–2031 (USD MILLION)
TABLE 265
NORTH AMERICA: ANATOMIC PATHOLOGY SERVICE MARKET FOR NON-SMALL CELL LUNG CANCER, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 266
EUROPE: ANATOMIC PATHOLOGY SERVICE MARKET FOR NON-SMALL CELL LUNG CANCER, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 267
ASIA PACIFIC: ANATOMIC PATHOLOGY SERVICE MARKET FOR NON-SMALL CELL LUNG CANCER, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 268
ANATOMIC PATHOLOGY SERVICE MARKET FOR PROSTATE CANCER, BY REGION, 2024–2031 (USD MILLION)
TABLE 269
NORTH AMERICA: ANATOMIC PATHOLOGY SERVICE MARKET FOR PROSTATE CANCER, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 270
EUROPE: ANATOMIC PATHOLOGY SERVICE MARKET FOR PROSTATE CANCER, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 271
ASIA PACIFIC: ANATOMIC PATHOLOGY SERVICE MARKET FOR PROSTATE CANCER, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 272
ANATOMIC PATHOLOGY SERVICE MARKET FOR GASTRIC CANCER, BY, BY REGION, 2024–2031 (USD MILLION)
TABLE 273
NORTH AMERICA: ANATOMIC PATHOLOGY SERVICE MARKET FOR GASTRIC CANCER, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 274
EUROPE: ANATOMIC PATHOLOGY SERVICE MARKET FOR GASTRIC CANCER, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 275
ASIA PACIFIC: ANATOMIC PATHOLOGY SERVICE MARKET FOR GASTRIC CANCER, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 276
ANATOMIC PATHOLOGY SERVICE MARKET FOR LYMPHOMA, BY, BY REGION, 2024–2031 (USD MILLION)
TABLE 277
NORTH AMERICA: ANATOMIC PATHOLOGY SERVICE MARKET FOR LYMPHOMA, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 278
EUROPE: ANATOMIC PATHOLOGY SERVICE MARKET FOR LYMPHOMA, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 279
ASIA PACIFIC: ANATOMIC PATHOLOGY SERVICE MARKET FOR LYMPHOMA, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 280
ANATOMIC PATHOLOGY SERVICE MARKET FOR OTHER DISEASE TYPE, BY REGION, 2024–2031 (USD MILLION)
TABLE 281
NORTH AMERICA: ANATOMIC PATHOLOGY SERVICE MARKET FOR OTHER DISEASE TYPE, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 282
EUROPE: ANATOMIC PATHOLOGY SERVICE MARKET FOR OTHER DISEASE TYPE, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 283
ASIA PACIFIC: ANATOMIC PATHOLOGY SERVICE MARKET FOR OTHER DISEASE TYPE, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 284
ANATOMIC PATHOLOGY MARKET, BY REGION, 2024–2031 (USD MILLION)
TABLE 285
NORTH AMERICA: ANATOMIC PATHOLOGY MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 286
NORTH AMERICA: ANATOMIC PATHOLOGY PRODUCT MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 287
NORTH AMERICA: ANATOMIC PATHOLOGY PRODUCT MARKET FOR CONSUMABLES, BY TYPE, 2024–2031 (USD MILLION)
TABLE 288
NORTH AMERICA: ANATOMIC PATHOLOGY PRODUCT MARKET FOR HISTOPATHOLOGY CONSUMABLES, BY TYPE, 2024–2031 (USD MILLION)
TABLE 289
NORTH AMERICA: ANATOMIC PATHOLOGY PRODUCT MARKET FOR HISTOPATHOLOGY ANTIBODIES, BY TYPE, 2024–2031 (USD MILLION)
TABLE 290
NORTH AMERICA: ANATOMIC PATHOLOGY PRODUCT MARKET FOR HISTOPATHOLOGY KITS & REAGENTS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 291
NORTH AMERICA: ANATOMIC PATHOLOGY PRODUCT MARKET FOR CYTOPATHOLOGY CONSUMABLES, BY TYPE, 2024–2031 (USD MILLION)
TABLE 292
NORTH AMERICA: ANATOMIC PATHOLOGY PRODUCT MARKET FOR CYTOPATHOLOGY ANTIBODIES, BY TYPE, 2024–2031 (USD MILLION)
TABLE 293
NORTH AMERICA: ANATOMIC PATHOLOGY PRODUCT MARKET FOR CYTOPATHOLOGY KITS & REAGENTS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 294
NORTH AMERICA: ANATOMIC PATHOLOGY PRODUCT MARKET FOR INSTRUMENTS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 295
NORTH AMERICA: ANATOMIC PATHOLOGY PRODUCT MARKET FOR SOFTWARE, BY TYPE, 2024–2031 (USD MILLION)
TABLE 296
NORTH AMERICA: ANATOMIC PATHOLOGY PRODUCT MARKET, BY PROCESS, 2024–2031 (USD MILLION)
TABLE 297
NORTH AMERICA: ANATOMIC PATHOLOGY PRODUCT MARKET, BY DISEASE, 2024–2031 (USD MILLION)
TABLE 298
NORTH AMERICA: ANATOMIC PATHOLOGY PRODUCT MARKET, BY END USER, 2024–2031 (USD MILLION)
TABLE 299
NORTH AMERICA: ANATOMIC PATHOLOGY SERVICE MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 300
NORTH AMERICA: ANATOMIC PATHOLOGY SERVICE MARKET, BY MODEL, 2024–2031 (USD MILLION)
TABLE 301
NORTH AMERICA: ANATOMIC PATHOLOGY SERVICE MARKET, BY DISEASE, 2024–2031 (USD MILLION)
TABLE 302
US CANCER INCIDENCE, BY CANCER TYPE, 2024 VS. 2050
TABLE 303
US: ANATOMIC PATHOLOGY PRODUCT MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 304
US: ANATOMIC PATHOLOGY PRODUCT MARKET FOR CONSUMABLES, BY TYPE, 2024–2031 (USD MILLION)
TABLE 305
US: ANATOMIC PATHOLOGY PRODUCT MARKET FOR HISTOPATHOLOGY CONSUMABLES, BY TYPE, 2024–2031 (USD MILLION)
TABLE 306
US: ANATOMIC PATHOLOGY PRODUCT MARKET FOR HISTOPATHOLOGY ANTIBODIES, BY TYPE, 2024–2031 (USD MILLION)
TABLE 307
US: ANATOMIC PATHOLOGY PRODUCT MARKET FOR HISTOPATHOLOGY KITS & REAGENTS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 308
US: ANATOMIC PATHOLOGY PRODUCT MARKET FOR CYTOPATHOLOGY CONSUMABLES, BY TYPE, 2024–2031 (USD MILLION)
TABLE 309
US: ANATOMIC PATHOLOGY PRODUCT MARKET FOR CYTOPATHOLOGY ANTIBODIES, BY TYPE, 2024–2031 (USD MILLION)
TABLE 310
US: ANATOMIC PATHOLOGY PRODUCT MARKET FOR CYTOPATHOLOGY KITS & REAGENTS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 311
US: ANATOMIC PATHOLOGY PRODUCT MARKET FOR INSTRUMENTS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 312
US: ANATOMIC PATHOLOGY PRODUCT MARKET FOR SOFTWARE, BY TYPE, 2024–2031 (USD MILLION)
TABLE 313
US: ANATOMIC PATHOLOGY PRODUCT MARKET, BY PROCESS, 2024–2031 (USD MILLION)
TABLE 314
US: ANATOMIC PATHOLOGY PRODUCT MARKET, BY DISEASE, 2024–2031 (USD MILLION)
TABLE 315
US: ANATOMIC PATHOLOGY PRODUCT MARKET, BY END USER, 2024–2031 (USD MILLION)
TABLE 316
US: ANATOMIC PATHOLOGY SERVICE MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 317
US: ANATOMIC PATHOLOGY SERVICE MARKET, BY MODEL, 2024–2031 (USD MILLION)
TABLE 318
US: ANATOMIC PATHOLOGY SERVICE MARKET, BY DISEASE, 2024–2031 (USD MILLION)
TABLE 319
CANADA CANCER INCIDENCE, BY CANCER TYPE, 2024 VS. 2050
TABLE 320
CANADA: ANATOMIC PATHOLOGY PRODUCT MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 321
CANADA: ANATOMIC PATHOLOGY PRODUCT MARKET FOR CONSUMABLES, BY TYPE, 2024–2031 (USD MILLION)
TABLE 322
CANADA: ANATOMIC PATHOLOGY PRODUCT MARKET FOR HISTOPATHOLOGY CONSUMABLES, BY TYPE, 2024–2031 (USD MILLION)
TABLE 323
CANADA: ANATOMIC PATHOLOGY PRODUCT MARKET FOR HISTOPATHOLOGY ANTIBODIES, BY TYPE, 2024–2031 (USD MILLION)
TABLE 324
CANADA: ANATOMIC PATHOLOGY PRODUCT MARKET FOR HISTOPATHOLOGY KITS & REAGENTS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 325
CANADA: ANATOMIC PATHOLOGY PRODUCT MARKET FOR CYTOPATHOLOGY CONSUMABLES, BY TYPE, 2024–2031 (USD MILLION)
TABLE 326
CANADA: ANATOMIC PATHOLOGY PRODUCT MARKET FOR CYTOPATHOLOGY ANTIBODIES, BY TYPE, 2024–2031 (USD MILLION)
TABLE 327
CANADA: ANATOMIC PATHOLOGY PRODUCT MARKET FOR CYTOPATHOLOGY KITS & REAGENTS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 328
CANADA: ANATOMIC PATHOLOGY PRODUCT MARKET FOR INSTRUMENTS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 329
CANADA: ANATOMIC PATHOLOGY PRODUCT MARKET FOR SOFTWARE, BY TYPE, 2024–2031 (USD MILLION)
TABLE 330
CANADA: ANATOMIC PATHOLOGY PRODUCT MARKET, BY PROCESS, 2024–2031 (USD MILLION)
TABLE 331
CANADA: ANATOMIC PATHOLOGY PRODUCT MARKET, BY DISEASE, 2024–2031 (USD MILLION)
TABLE 332
CANADA: ANATOMIC PATHOLOGY PRODUCT MARKET, BY END USER, 2024–2031 (USD MILLION)
TABLE 333
CANADA: ANATOMIC PATHOLOGY SERVICE MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 334
CANADA: ANATOMIC PATHOLOGY SERVICE MARKET, BY MODEL, 2024–2031 (USD MILLION)
TABLE 335
CANADA: ANATOMIC PATHOLOGY SERVICE MARKET, BY DISEASE, 2024–2031 (USD MILLION)
TABLE 336
EUROPE: ANATOMIC PATHOLOGY MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 337
EUROPE: ANATOMIC PATHOLOGY PRODUCT MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 338
EUROPE: ANATOMIC PATHOLOGY PRODUCT MARKET FOR CONSUMABLES, BY TYPE, 2024–2031 (USD MILLION)
TABLE 339
EUROPE: ANATOMIC PATHOLOGY PRODUCT MARKET FOR HISTOPATHOLOGY CONSUMABLES, BY TYPE, 2024–2031 (USD MILLION)
TABLE 340
EUROPE: ANATOMIC PATHOLOGY PRODUCT MARKET FOR HISTOPATHOLOGY ANTIBODIES, BY TYPE, 2024–2031 (USD MILLION)
TABLE 341
EUROPE: ANATOMIC PATHOLOGY PRODUCT MARKET FOR HISTOPATHOLOGY KITS & REAGENTS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 342
EUROPE: ANATOMIC PATHOLOGY PRODUCT MARKET FOR CYTOPATHOLOGY CONSUMABLES, BY TYPE, 2024–2031 (USD MILLION)
TABLE 343
EUROPE: ANATOMIC PATHOLOGY PRODUCT MARKET FOR CYTOPATHOLOGY ANTIBODIES, BY TYPE, 2024–2031 (USD MILLION)
TABLE 344
EUROPE: ANATOMIC PATHOLOGY PRODUCT MARKET FOR CYTOPATHOLOGY KITS & REAGENTS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 345
EUROPE: ANATOMIC PATHOLOGY PRODUCT MARKET FOR INSTRUMENTS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 346
EUROPE: ANATOMIC PATHOLOGY PRODUCT MARKET FOR SOFTWARE, BY TYPE, 2024–2031 (USD MILLION)
TABLE 347
EUROPE: ANATOMIC PATHOLOGY PRODUCT MARKET, BY PROCESS, 2024–2031 (USD MILLION)
TABLE 348
EUROPE: ANATOMIC PATHOLOGY PRODUCT MARKET, BY DISEASE, 2024–2031 (USD MILLION)
TABLE 349
EUROPE: ANATOMIC PATHOLOGY PRODUCT MARKET, BY END USER, 2024–2031 (USD MILLION)
TABLE 350
EUROPE: ANATOMIC PATHOLOGY SERVICE MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 351
EUROPE: ANATOMIC PATHOLOGY SERVICE MARKET, BY MODEL, 2024–2031 (USD MILLION)
TABLE 352
EUROPE: ANATOMIC PATHOLOGY SERVICE MARKET, BY DISEASE, 2024–2031 (USD MILLION)
TABLE 353
GERMANY: CANCER INCIDENCE, BY TYPE, 2024 VS. 2050
TABLE 354
GERMANY: ANATOMIC PATHOLOGY PRODUCT MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 355
GERMANY: ANATOMIC PATHOLOGY PRODUCT MARKET FOR CONSUMABLES, BY TYPE, 2024–2031 (USD MILLION)
TABLE 356
GERMANY: ANATOMIC PATHOLOGY PRODUCT MARKET FOR HISTOPATHOLOGY CONSUMABLES, BY TYPE, 2024–2031 (USD MILLION)
TABLE 357
GERMANY: ANATOMIC PATHOLOGY PRODUCT MARKET FOR HISTOPATHOLOGY ANTIBODIES, BY TYPE, 2024–2031 (USD MILLION)
TABLE 358
GERMANY: ANATOMIC PATHOLOGY PRODUCT MARKET FOR HISTOPATHOLOGY KITS & REAGENTS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 359
GERMANY: ANATOMIC PATHOLOGY PRODUCT MARKET FOR CYTOPATHOLOGY CONSUMABLES, BY TYPE, 2024–2031 (USD MILLION)
TABLE 360
GERMANY: ANATOMIC PATHOLOGY PRODUCT MARKET FOR CYTOPATHOLOGY ANTIBODIES, BY TYPE, 2024–2031 (USD MILLION)
TABLE 361
GERMANY: ANATOMIC PATHOLOGY PRODUCT MARKET FOR CYTOPATHOLOGY KITS & REAGENTS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 362
GERMANY: ANATOMIC PATHOLOGY PRODUCT MARKET FOR INSTRUMENTS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 363
GERMANY: ANATOMIC PATHOLOGY PRODUCT MARKET FOR SOFTWARE, BY TYPE, 2024–2031 (USD MILLION)
TABLE 364
GERMANY: ANATOMIC PATHOLOGY PRODUCT MARKET, BY PROCESS, 2024–2031 (USD MILLION)
TABLE 365
GERMANY: ANATOMIC PATHOLOGY PRODUCT MARKET, BY DISEASE, 2024–2031 (USD MILLION)
TABLE 366
GERMANY: ANATOMIC PATHOLOGY PRODUCT MARKET, BY END USER, 2024–2031 (USD MILLION)
TABLE 367
GERMANY: ANATOMIC PATHOLOGY SERVICE MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 368
GERMANY: ANATOMIC PATHOLOGY SERVICE MARKET, BY MODEL, 2024–2031 (USD MILLION)
TABLE 369
GERMANY: ANATOMIC PATHOLOGY SERVICE MARKET, BY DISEASE, 2024–2031 (USD MILLION)
TABLE 370
UK: ANATOMIC PATHOLOGY PRODUCT MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 371
UK: ANATOMIC PATHOLOGY PRODUCT MARKET FOR CONSUMABLES, BY TYPE, 2024–2031 (USD MILLION)
TABLE 372
UK: ANATOMIC PATHOLOGY PRODUCT MARKET FOR HISTOPATHOLOGY CONSUMABLES, BY TYPE, 2024–2031 (USD MILLION)
TABLE 373
UK: ANATOMIC PATHOLOGY PRODUCT MARKET FOR HISTOPATHOLOGY ANTIBODIES, BY TYPE, 2024–2031 (USD MILLION)
TABLE 374
UK: ANATOMIC PATHOLOGY PRODUCT MARKET FOR HISTOPATHOLOGY KITS & REAGENTS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 375
UK: ANATOMIC PATHOLOGY PRODUCT MARKET FOR CYTOPATHOLOGY CONSUMABLES, BY TYPE, 2024–2031 (USD MILLION)
TABLE 376
UK: ANATOMIC PATHOLOGY PRODUCT MARKET FOR CYTOPATHOLOGY ANTIBODIES, BY TYPE, 2024–2031 (USD MILLION)
TABLE 377
UK: ANATOMIC PATHOLOGY PRODUCT MARKET FOR CYTOPATHOLOGY KITS & REAGENTS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 378
UK: ANATOMIC PATHOLOGY PRODUCT MARKET FOR INSTRUMENTS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 379
UK: ANATOMIC PATHOLOGY PRODUCT MARKET FOR SOFTWARE, BY TYPE, 2024–2031 (USD MILLION)
TABLE 380
UK: ANATOMIC PATHOLOGY PRODUCT MARKET, BY PROCESS, 2024–2031 (USD MILLION)
TABLE 381
UK: ANATOMIC PATHOLOGY PRODUCT MARKET, BY DISEASE, 2024–2031 (USD MILLION)
TABLE 382
UK: ANATOMIC PATHOLOGY PRODUCT MARKET, BY END USER, 2024–2031 (USD MILLION)
TABLE 383
UK: ANATOMIC PATHOLOGY SERVICE MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 384
UK: ANATOMIC PATHOLOGY SERVICE MARKET, BY MODEL, 2024–2031 (USD MILLION)
TABLE 385
UK: ANATOMIC PATHOLOGY SERVICE MARKET, BY DISEASE, 2024–2031 (USD MILLION)
TABLE 386
FRANCE: CANCER INCIDENCE, BY TYPE, 2024 VS. 2050
TABLE 387
FRANCE: ANATOMIC PATHOLOGY PRODUCT MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 388
FRANCE: ANATOMIC PATHOLOGY PRODUCT MARKET FOR CONSUMABLES, BY TYPE, 2024–2031 (USD MILLION)
TABLE 389
FRANCE: ANATOMIC PATHOLOGY PRODUCT MARKET FOR HISTOPATHOLOGY CONSUMABLES, BY TYPE, 2024–2031 (USD MILLION)
TABLE 390
FRANCE: ANATOMIC PATHOLOGY PRODUCT MARKET FOR HISTOPATHOLOGY ANTIBODIES, BY TYPE, 2024–2031 (USD MILLION)
TABLE 391
FRANCE: ANATOMIC PATHOLOGY PRODUCT MARKET FOR HISTOPATHOLOGY KITS & REAGENTS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 392
FRANCE: ANATOMIC PATHOLOGY PRODUCT MARKET FOR CYTOPATHOLOGY CONSUMABLES, BY TYPE, 2024–2031 (USD MILLION)
TABLE 393
FRANCE: ANATOMIC PATHOLOGY PRODUCT MARKET FOR CYTOPATHOLOGY ANTIBODIES, BY TYPE, 2024–2031 (USD MILLION)
TABLE 394
FRANCE: ANATOMIC PATHOLOGY PRODUCT MARKET FOR CYTOPATHOLOGY KITS & REAGENTS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 395
FRANCE: ANATOMIC PATHOLOGY PRODUCT MARKET FOR INSTRUMENTS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 396
FRANCE: ANATOMIC PATHOLOGY PRODUCT MARKET FOR SOFTWARE, BY TYPE, 2024–2031 (USD MILLION)
TABLE 397
FRANCE: ANATOMIC PATHOLOGY PRODUCT MARKET, BY PROCESS, 2024–2031 (USD MILLION)
TABLE 398
FRANCE: ANATOMIC PATHOLOGY PRODUCT MARKET, BY DISEASE, 2024–2031 (USD MILLION)
TABLE 399
FRANCE: ANATOMIC PATHOLOGY PRODUCT MARKET, BY END USER, 2024–2031 (USD MILLION)
TABLE 400
FRANCE: ANATOMIC PATHOLOGY SERVICE MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 401
FRANCE: ANATOMIC PATHOLOGY SERVICE MARKET, BY MODEL, 2024–2031 (USD MILLION)
TABLE 402
FRANCE: ANATOMIC PATHOLOGY SERVICE MARKET, BY DISEASE, 2024–2031 (USD MILLION)
TABLE 403
ITALY: CANCER INCIDENCE, BY TYPE, 2024 VS. 2050
TABLE 404
ITALY: ANATOMIC PATHOLOGY PRODUCT MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 405
ITALY: ANATOMIC PATHOLOGY PRODUCT MARKET FOR CONSUMABLES, BY TYPE, 2024–2031 (USD MILLION)
TABLE 406
ITALY: ANATOMIC PATHOLOGY PRODUCT MARKET FOR HISTOPATHOLOGY CONSUMABLES, BY TYPE, 2024–2031 (USD MILLION)
TABLE 407
ITALY: ANATOMIC PATHOLOGY PRODUCT MARKET FOR HISTOPATHOLOGY ANTIBODIES, BY TYPE, 2024–2031 (USD MILLION)
TABLE 408
ITALY: ANATOMIC PATHOLOGY PRODUCT MARKET FOR HISTOPATHOLOGY KITS & REAGENTS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 409
ITALY: ANATOMIC PATHOLOGY PRODUCT MARKET FOR CYTOPATHOLOGY CONSUMABLES, BY TYPE, 2024–2031 (USD MILLION)
TABLE 410
ITALY: ANATOMIC PATHOLOGY PRODUCT MARKET FOR CYTOPATHOLOGY ANTIBODIES, BY TYPE, 2024–2031 (USD MILLION)
TABLE 411
ITALY: ANATOMIC PATHOLOGY PRODUCT MARKET FOR CYTOPATHOLOGY KITS & REAGENTS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 412
ITALY: ANATOMIC PATHOLOGY PRODUCT MARKET FOR INSTRUMENTS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 413
ITALY: ANATOMIC PATHOLOGY PRODUCT MARKET FOR SOFTWARE, BY TYPE, 2024–2031 (USD MILLION)
TABLE 414
ITALY: ANATOMIC PATHOLOGY PRODUCT MARKET, BY PROCESS, 2024–2031 (USD MILLION)
TABLE 415
ITALY: ANATOMIC PATHOLOGY PRODUCT MARKET, BY DISEASE, 2024–2031 (USD MILLION)
TABLE 416
ITALY: ANATOMIC PATHOLOGY PRODUCT MARKET, BY END USER, 2024–2031 (USD MILLION)
TABLE 417
ITALY: ANATOMIC PATHOLOGY SERVICE MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 418
ITALY: ANATOMIC PATHOLOGY SERVICE MARKET, BY MODEL, 2024–2031 (USD MILLION)
TABLE 419
ITALY: ANATOMIC PATHOLOGY SERVICE MARKET, BY DISEASE, 2024–2031 (USD MILLION)
TABLE 420
SPAIN: CANCER INCIDENCE, BY TYPE, 2024 VS. 2050
TABLE 421
SPAIN: ANATOMIC PATHOLOGY PRODUCT MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 422
SPAIN: ANATOMIC PATHOLOGY PRODUCT MARKET FOR CONSUMABLES, BY TYPE, 2024–2031 (USD MILLION)
TABLE 423
SPAIN: ANATOMIC PATHOLOGY PRODUCT MARKET FOR HISTOPATHOLOGY CONSUMABLES, BY TYPE, 2024–2031 (USD MILLION)
TABLE 424
SPAIN: ANATOMIC PATHOLOGY PRODUCT MARKET FOR HISTOPATHOLOGY ANTIBODIES, BY TYPE, 2024–2031 (USD MILLION)
TABLE 425
SPAIN: ANATOMIC PATHOLOGY PRODUCT MARKET FOR HISTOPATHOLOGY KITS & REAGENTS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 426
SPAIN: ANATOMIC PATHOLOGY PRODUCT MARKET FOR CYTOPATHOLOGY CONSUMABLES, BY TYPE, 2024–2031 (USD MILLION)
TABLE 427
SPAIN: ANATOMIC PATHOLOGY PRODUCT MARKET FOR CYTOPATHOLOGY ANTIBODIES, BY TYPE, 2024–2031 (USD MILLION)
TABLE 428
SPAIN: ANATOMIC PATHOLOGY PRODUCT MARKET FOR CYTOPATHOLOGY KITS & REAGENTS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 429
SPAIN: ANATOMIC PATHOLOGY PRODUCT MARKET FOR INSTRUMENTS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 430
SPAIN: ANATOMIC PATHOLOGY PRODUCT MARKET FOR SOFTWARE, BY TYPE, 2024–2031 (USD MILLION)
TABLE 431
SPAIN: ANATOMIC PATHOLOGY PRODUCT MARKET, BY PROCESS, 2024–2031 (USD MILLION)
TABLE 432
SPAIN: ANATOMIC PATHOLOGY PRODUCT MARKET, BY DISEASE, 2024–2031 (USD MILLION)
TABLE 433
SPAIN: ANATOMIC PATHOLOGY PRODUCT MARKET, BY END USER, 2024–2031 (USD MILLION)
TABLE 434
SPAIN: ANATOMIC PATHOLOGY SERVICE MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 435
SPAIN: ANATOMIC PATHOLOGY SERVICE MARKET, BY MODEL, 2024–2031 (USD MILLION)
TABLE 436
SPAIN: ANATOMIC PATHOLOGY SERVICE MARKET, BY DISEASE, 2024–2031 (USD MILLION)
TABLE 437
REST OF EUROPE: ANATOMIC PATHOLOGY PRODUCT MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 438
REST OF EUROPE: ANATOMIC PATHOLOGY PRODUCT MARKET FOR CONSUMABLES, BY TYPE, 2024–2031 (USD MILLION)
TABLE 439
REST OF EUROPE: ANATOMIC PATHOLOGY PRODUCT MARKET FOR HISTOPATHOLOGY CONSUMABLES, BY TYPE, 2024–2031 (USD MILLION)
TABLE 440
REST OF EUROPE: ANATOMIC PATHOLOGY PRODUCT MARKET FOR HISTOPATHOLOGY ANTIBODIES, BY TYPE, 2024–2031 (USD MILLION)
TABLE 441
REST OF EUROPE: ANATOMIC PATHOLOGY PRODUCT MARKET FOR HISTOPATHOLOGY KITS & REAGENTS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 442
REST OF EUROPE: ANATOMIC PATHOLOGY PRODUCT MARKET FOR CYTOPATHOLOGY CONSUMABLES, BY TYPE, 2024–2031 (USD MILLION)
TABLE 443
REST OF EUROPE: ANATOMIC PATHOLOGY PRODUCT MARKET FOR CYTOPATHOLOGY ANTIBODIES, BY TYPE, 2024–2031 (USD MILLION)
TABLE 444
REST OF EUROPE: ANATOMIC PATHOLOGY PRODUCT MARKET FOR CYTOPATHOLOGY KITS & REAGENTS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 445
REST OF EUROPE: ANATOMIC PATHOLOGY PRODUCT MARKET FOR INSTRUMENTS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 446
REST OF EUROPE: ANATOMIC PATHOLOGY PRODUCT MARKET FOR SOFTWARE, BY TYPE, 2024–2031 (USD MILLION)
TABLE 447
REST OF EUROPE: ANATOMIC PATHOLOGY PRODUCT MARKET, BY PROCESS, 2024–2031 (USD MILLION)
TABLE 448
REST OF EUROPE: ANATOMIC PATHOLOGY PRODUCT MARKET, BY DISEASE, 2024–2031 (USD MILLION)
TABLE 449
REST OF EUROPE: ANATOMIC PATHOLOGY PRODUCT MARKET, BY END USER, 2024–2031 (USD MILLION)
TABLE 450
REST OF EUROPE: ANATOMIC PATHOLOGY SERVICE MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 451
REST OF EUROPE: ANATOMIC PATHOLOGY SERVICE MARKET, BY MODEL, 2024–2031 (USD MILLION)
TABLE 452
REST OF EUROPE: ANATOMIC PATHOLOGY SERVICE MARKET, BY DISEASE, 2024–2031 (USD MILLION)
TABLE 453
ASIA PACIFIC: ANATOMIC PATHOLOGY MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 454
ASIA PACIFIC: ANATOMIC PATHOLOGY PRODUCT MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 455
ASIA PACIFIC: ANATOMIC PATHOLOGY PRODUCT MARKET FOR CONSUMABLES, BY TYPE, 2024–2031 (USD MILLION)
TABLE 456
ASIA PACIFIC: ANATOMIC PATHOLOGY PRODUCT MARKET FOR HISTOPATHOLOGY CONSUMABLES, BY TYPE, 2024–2031 (USD MILLION)
TABLE 457
ASIA PACIFIC: ANATOMIC PATHOLOGY PRODUCT MARKET FOR HISTOPATHOLOGY ANTIBODIES, BY TYPE, 2024–2031 (USD MILLION)
TABLE 458
ASIA PACIFIC: ANATOMIC PATHOLOGY PRODUCT MARKET FOR HISTOPATHOLOGY KITS & REAGENTS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 459
ASIA PACIFIC: ANATOMIC PATHOLOGY PRODUCT MARKET FOR CYTOPATHOLOGY CONSUMABLES, BY TYPE, 2024–2031 (USD MILLION)
TABLE 460
ASIA PACIFIC: ANATOMIC PATHOLOGY PRODUCT MARKET FOR CYTOPATHOLOGY ANTIBODIES, BY TYPE, 2024–2031 (USD MILLION)
TABLE 461
ASIA PACIFIC: ANATOMIC PATHOLOGY PRODUCT MARKET FOR CYTOPATHOLOGY KITS & REAGENTS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 462
ASIA PACIFIC: ANATOMIC PATHOLOGY PRODUCT MARKET FOR INSTRUMENTS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 463
ASIA PACIFIC: ANATOMIC PATHOLOGY PRODUCT MARKET FOR SOFTWARE, BY TYPE, 2024–2031 (USD MILLION)
TABLE 464
ASIA PACIFIC: ANATOMIC PATHOLOGY PRODUCT MARKET, BY PROCESS, 2024–2031 (USD MILLION)
TABLE 465
ASIA PACIFIC: ANATOMIC PATHOLOGY PRODUCT MARKET, BY DISEASE, 2024–2031 (USD MILLION)
TABLE 466
ASIA PACIFIC: ANATOMIC PATHOLOGY PRODUCT MARKET, BY END USER, 2024–2031 (USD MILLION)
TABLE 467
ASIA PACIFIC: ANATOMIC PATHOLOGY SERVICE MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 468
ASIA PACIFIC: ANATOMIC PATHOLOGY SERVICE MARKET, BY MODEL, 2024–2031 (USD MILLION)
TABLE 469
ASIA PACIFIC: ANATOMIC PATHOLOGY SERVICE MARKET, BY DISEASE, 2024–2031 (USD MILLION)
TABLE 470
CHINA: ANATOMIC PATHOLOGY PRODUCT MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 471
CHINA: ANATOMIC PATHOLOGY PRODUCT MARKET FOR CONSUMABLES, BY TYPE, 2024–2031 (USD MILLION)
TABLE 472
CHINA: ANATOMIC PATHOLOGY PRODUCT MARKET FOR HISTOPATHOLOGY CONSUMABLES, BY TYPE, 2024–2031 (USD MILLION)
TABLE 473
CHINA: ANATOMIC PATHOLOGY PRODUCT MARKET FOR HISTOPATHOLOGY ANTIBODIES, BY TYPE, 2024–2031 (USD MILLION)
TABLE 474
CHINA: ANATOMIC PATHOLOGY PRODUCT MARKET FOR HISTOPATHOLOGY KITS & REAGENTS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 475
CHINA: ANATOMIC PATHOLOGY PRODUCT MARKET FOR CYTOPATHOLOGY CONSUMABLES, BY TYPE, 2024–2031 (USD MILLION)
TABLE 476
CHINA: ANATOMIC PATHOLOGY PRODUCT MARKET FOR CYTOPATHOLOGY ANTIBODIES, BY TYPE, 2024–2031 (USD MILLION)
TABLE 477
CHINA: ANATOMIC PATHOLOGY PRODUCT MARKET FOR CYTOPATHOLOGY KITS & REAGENTS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 478
CHINA: ANATOMIC PATHOLOGY PRODUCT MARKET FOR INSTRUMENTS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 479
CHINA: ANATOMIC PATHOLOGY PRODUCT MARKET FOR SOFTWARE, BY TYPE, 2024–2031 (USD MILLION)
TABLE 480
CHINA: ANATOMIC PATHOLOGY PRODUCT MARKET, BY PROCESS, 2024–2031 (USD MILLION)
TABLE 481
CHINA: ANATOMIC PATHOLOGY PRODUCT MARKET, BY DISEASE, 2024–2031 (USD MILLION)
TABLE 482
CHINA: ANATOMIC PATHOLOGY PRODUCT MARKET, BY END USER, 2024–2031 (USD MILLION)
TABLE 483
CHINA: ANATOMIC PATHOLOGY SERVICE MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 484
CHINA: ANATOMIC PATHOLOGY SERVICE MARKET, BY MODEL, 2024–2031 (USD MILLION)
TABLE 485
CHINA: ANATOMIC PATHOLOGY SERVICE MARKET, BY DISEASE, 2024–2031 (USD MILLION)
TABLE 486
CANCER INCIDENCE, BY CANCER TYPE (JAPAN), 2024 VS. 2050
TABLE 487
JAPAN: ANATOMIC PATHOLOGY PRODUCT MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 488
JAPAN: ANATOMIC PATHOLOGY PRODUCT MARKET FOR CONSUMABLES, BY TYPE, 2024–2031 (USD MILLION)
TABLE 489
JAPAN: ANATOMIC PATHOLOGY PRODUCT MARKET FOR HISTOPATHOLOGY CONSUMABLES, BY TYPE, 2024–2031 (USD MILLION)
TABLE 490
JAPAN: ANATOMIC PATHOLOGY PRODUCT MARKET FOR HISTOPATHOLOGY ANTIBODIES, BY TYPE, 2024–2031 (USD MILLION)
TABLE 491
JAPAN: ANATOMIC PATHOLOGY PRODUCT MARKET FOR HISTOPATHOLOGY KITS & REAGENTS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 492
JAPAN: ANATOMIC PATHOLOGY PRODUCT MARKET FOR CYTOPATHOLOGY CONSUMABLES, BY TYPE, 2024–2031 (USD MILLION)
TABLE 493
JAPAN: ANATOMIC PATHOLOGY PRODUCT MARKET FOR CYTOPATHOLOGY ANTIBODIES, BY TYPE, 2024–2031 (USD MILLION)
TABLE 494
JAPAN: ANATOMIC PATHOLOGY PRODUCT MARKET FOR CYTOPATHOLOGY KITS & REAGENTS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 495
JAPAN: ANATOMIC PATHOLOGY PRODUCT MARKET FOR INSTRUMENTS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 496
JAPAN: ANATOMIC PATHOLOGY PRODUCT MARKET FOR SOFTWARE, BY TYPE, 2024–2031 (USD MILLION)
TABLE 497
JAPAN: ANATOMIC PATHOLOGY PRODUCT MARKET, BY PROCESS, 2024–2031 (USD MILLION)
TABLE 498
JAPAN: ANATOMIC PATHOLOGY PRODUCT MARKET, BY DISEASE, 2024–2031 (USD MILLION)
TABLE 499
JAPAN: ANATOMIC PATHOLOGY PRODUCT MARKET, BY END USER, 2024–2031 (USD MILLION)
TABLE 500
JAPAN: ANATOMIC PATHOLOGY SERVICE MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 501
JAPAN: ANATOMIC PATHOLOGY SERVICE MARKET, BY MODEL, 2024–2031 (USD MILLION)
TABLE 502
JAPAN: ANATOMIC PATHOLOGY SERVICE MARKET, BY DISEASE, 2024–2031 (USD MILLION)
TABLE 503
INDIA: ANATOMIC PATHOLOGY PRODUCT MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 504
INDIA: ANATOMIC PATHOLOGY PRODUCT MARKET FOR CONSUMABLES, BY TYPE, 2024–2031 (USD MILLION)
TABLE 505
INDIA: ANATOMIC PATHOLOGY PRODUCT MARKET FOR HISTOPATHOLOGY CONSUMABLES, BY TYPE, 2024–2031 (USD MILLION)
TABLE 506
INDIA: ANATOMIC PATHOLOGY PRODUCT MARKET FOR HISTOPATHOLOGY ANTIBODIES, BY TYPE, 2024–2031 (USD MILLION)
TABLE 507
INDIA: ANATOMIC PATHOLOGY PRODUCT MARKET FOR HISTOPATHOLOGY KITS & REAGENTS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 508
INDIA: ANATOMIC PATHOLOGY PRODUCT MARKET FOR CYTOPATHOLOGY CONSUMABLES, BY TYPE, 2024–2031 (USD MILLION)
TABLE 509
INDIA: ANATOMIC PATHOLOGY PRODUCT MARKET FOR CYTOPATHOLOGY ANTIBODIES, BY TYPE, 2024–2031 (USD MILLION)
TABLE 510
INDIA: ANATOMIC PATHOLOGY PRODUCT MARKET FOR CYTOPATHOLOGY KITS & REAGENTS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 511
INDIA: ANATOMIC PATHOLOGY PRODUCT MARKET FOR INSTRUMENTS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 512
INDIA: ANATOMIC PATHOLOGY PRODUCT MARKET FOR SOFTWARE, BY TYPE, 2024–2031 (USD MILLION)
TABLE 513
INDIA: ANATOMIC PATHOLOGY PRODUCT MARKET, BY PROCESS, 2024–2031 (USD MILLION)
TABLE 514
INDIA: ANATOMIC PATHOLOGY PRODUCT MARKET, BY DISEASE, 2024–2031 (USD MILLION)
TABLE 515
INDIA: ANATOMIC PATHOLOGY PRODUCT MARKET, BY END USER, 2024–2031 (USD MILLION)
TABLE 516
INDIA: ANATOMIC PATHOLOGY SERVICE MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 517
INDIA: ANATOMIC PATHOLOGY SERVICE MARKET, BY MODEL, 2024–2031 (USD MILLION)
TABLE 518
INDIA: ANATOMIC PATHOLOGY SERVICE MARKET, BY DISEASE, 2024–2031 (USD MILLION)
TABLE 519
REST OF ASIA PACIFIC: ANATOMIC PATHOLOGY PRODUCT MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 520
REST OF ASIA PACIFIC: ANATOMIC PATHOLOGY PRODUCT MARKET FOR CONSUMABLES, BY TYPE, 2024–2031 (USD MILLION)
TABLE 521
REST OF ASIA PACIFIC: ANATOMIC PATHOLOGY PRODUCT MARKET FOR HISTOPATHOLOGY CONSUMABLES, BY TYPE, 2024–2031 (USD MILLION)
TABLE 522
REST OF ASIA PACIFIC: ANATOMIC PATHOLOGY PRODUCT MARKET FOR HISTOPATHOLOGY ANTIBODIES, BY TYPE, 2024–2031 (USD MILLION)
TABLE 523
REST OF ASIA PACIFIC: ANATOMIC PATHOLOGY PRODUCT MARKET FOR HISTOPATHOLOGY KITS & REAGENTS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 524
REST OF ASIA PACIFIC: ANATOMIC PATHOLOGY PRODUCT MARKET FOR CYTOPATHOLOGY CONSUMABLES, BY TYPE, 2024–2031 (USD MILLION)
TABLE 525
REST OF ASIA PACIFIC: ANATOMIC PATHOLOGY PRODUCT MARKET FOR CYTOPATHOLOGY ANTIBODIES, BY TYPE, 2024–2031 (USD MILLION)
TABLE 526
REST OF ASIA PACIFIC: ANATOMIC PATHOLOGY PRODUCT MARKET FOR CYTOPATHOLOGY KITS & REAGENTS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 527
REST OF ASIA PACIFIC: ANATOMIC PATHOLOGY PRODUCT MARKET FOR INSTRUMENTS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 528
REST OF ASIA PACIFIC: ANATOMIC PATHOLOGY PRODUCT MARKET FOR SOFTWARE, BY TYPE, 2024–2031 (USD MILLION)
TABLE 529
REST OF ASIA PACIFIC: ANATOMIC PATHOLOGY PRODUCT MARKET, BY PROCESS, 2024–2031 (USD MILLION)
TABLE 530
REST OF ASIA PACIFIC: ANATOMIC PATHOLOGY PRODUCT MARKET, BY DISEASE, 2024–2031 (USD MILLION)
TABLE 531
REST OF ASIA PACIFIC: ANATOMIC PATHOLOGY PRODUCT MARKET, BY END USER, 2024–2031 (USD MILLION)
TABLE 532
REST OF ASIA PACIFIC: ANATOMIC PATHOLOGY SERVICE MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 533
REST OF ASIA PACIFIC: ANATOMIC PATHOLOGY SERVICE MARKET, BY MODEL, 2024–2031 (USD MILLION)
TABLE 534
REST OF ASIA PACIFIC: ANATOMIC PATHOLOGY SERVICE MARKET, BY DISEASE, 2024–2031 (USD MILLION)
TABLE 535
LATIN AMERICA: ANATOMIC PATHOLOGY PRODUCT MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 536
LATIN AMERICA: ANATOMIC PATHOLOGY PRODUCT MARKET FOR CONSUMABLES, BY TYPE, 2024–2031 (USD MILLION)
TABLE 537
LATIN AMERICA: ANATOMIC PATHOLOGY PRODUCT MARKET FOR HISTOPATHOLOGY CONSUMABLES, BY TYPE, 2024–2031 (USD MILLION)
TABLE 538
LATIN AMERICA: ANATOMIC PATHOLOGY PRODUCT MARKET FOR HISTOPATHOLOGY ANTIBODIES, BY TYPE, 2024–2031 (USD MILLION)
TABLE 539
LATIN AMERICA: ANATOMIC PATHOLOGY PRODUCT MARKET FOR HISTOPATHOLOGY KITS & REAGENTS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 540
LATIN AMERICA: ANATOMIC PATHOLOGY PRODUCT MARKET FOR CYTOPATHOLOGY CONSUMABLES, BY TYPE, 2024–2031 (USD MILLION)
TABLE 541
LATIN AMERICA: ANATOMIC PATHOLOGY PRODUCT MARKET FOR CYTOPATHOLOGY ANTIBODIES, BY TYPE, 2024–2031 (USD MILLION)
TABLE 542
LATIN AMERICA: ANATOMIC PATHOLOGY PRODUCT MARKET FOR CYTOPATHOLOGY KITS & REAGENTS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 543
LATIN AMERICA: ANATOMIC PATHOLOGY PRODUCT MARKET FOR INSTRUMENTS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 544
LATIN AMERICA: ANATOMIC PATHOLOGY PRODUCT MARKET FOR SOFTWARE, BY TYPE, 2024–2031 (USD MILLION)
TABLE 545
LATIN AMERICA: ANATOMIC PATHOLOGY PRODUCT MARKET, BY PROCESS, 2024–2031 (USD MILLION)
TABLE 546
LATIN AMERICA: ANATOMIC PATHOLOGY PRODUCT MARKET, BY DISEASE, 2024–2031 (USD MILLION)
TABLE 547
LATIN AMERICA: ANATOMIC PATHOLOGY PRODUCT MARKET, BY END USER, 2024–2031 (USD MILLION)
TABLE 548
LATIN AMERICA: ANATOMIC PATHOLOGY SERVICE MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 549
LATIN AMERICA: ANATOMIC PATHOLOGY SERVICE MARKET, BY MODEL, 2024–2031 (USD MILLION)
TABLE 550
LATIN AMERICA: ANATOMIC PATHOLOGY SERVICE MARKET, BY DISEASE, 2024–2031 (USD MILLION)
TABLE 551
MIDDLE EAST & AFRICA: ANATOMIC PATHOLOGY PRODUCT MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 552
MIDDLE EAST & AFRICA: ANATOMIC PATHOLOGY PRODUCT MARKET FOR CONSUMABLES, BY TYPE, 2024–2031 (USD MILLION)
TABLE 553
MIDDLE EAST & AFRICA: ANATOMIC PATHOLOGY PRODUCT MARKET FOR HISTOPATHOLOGY CONSUMABLES, BY TYPE, 2024–2031 (USD MILLION)
TABLE 554
MIDDLE EAST & AFRICA: ANATOMIC PATHOLOGY PRODUCT MARKET FOR HISTOPATHOLOGY ANTIBODIES, BY TYPE, 2024–2031 (USD MILLION)
TABLE 555
MIDDLE EAST & AFRICA: ANATOMIC PATHOLOGY PRODUCT MARKET FOR HISTOPATHOLOGY KITS & REAGENTS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 556
MIDDLE EAST & AFRICA: ANATOMIC PATHOLOGY PRODUCT MARKET FOR CYTOPATHOLOGY CONSUMABLES, BY TYPE, 2024–2031 (USD MILLION)
TABLE 557
MIDDLE EAST & AFRICA: ANATOMIC PATHOLOGY PRODUCT MARKET FOR CYTOPATHOLOGY ANTIBODIES, BY TYPE, 2024–2031 (USD MILLION)
TABLE 558
MIDDLE EAST & AFRICA: ANATOMIC PATHOLOGY PRODUCT MARKET FOR CYTOPATHOLOGY KITS & REAGENTS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 559
MIDDLE EAST & AFRICA: ANATOMIC PATHOLOGY PRODUCT MARKET FOR INSTRUMENTS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 560
MIDDLE EAST & AFRICA: ANATOMIC PATHOLOGY PRODUCT MARKET FOR SOFTWARE, BY TYPE, 2024–2031 (USD MILLION)
TABLE 561
MIDDLE EAST & AFRICA: ANATOMIC PATHOLOGY PRODUCT MARKET, BY PROCESS, 2024–2031 (USD MILLION)
TABLE 562
MIDDLE EAST & AFRICA: ANATOMIC PATHOLOGY PRODUCT MARKET, BY DISEASE, 2024–2031 (USD MILLION)
TABLE 563
MIDDLE EAST & AFRICA: ANATOMIC PATHOLOGY PRODUCT MARKET, BY END USER, 2024–2031 (USD MILLION)
TABLE 564
MIDDLE EAST & AFRICA: ANATOMIC PATHOLOGY SERVICE MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 565
MIDDLE EAST & AFRICA: ANATOMIC PATHOLOGY SERVICE MARKET, BY MODEL, 2024–2031 (USD MILLION)
TABLE 566
MIDDLE EAST & AFRICA: ANATOMIC PATHOLOGY SERVICE MARKET, BY DISEASE, 2024–2031 (USD MILLION)
TABLE 567
OVERVIEW OF STRATEGIES DEPLOYED BY KEY COMPANIES IN ANATOMIC PATHOLOGY MARKET, JANUARY 2023–JULY 2026
TABLE 568
ANATOMIC PATHOLOGY MARKET: DEGREE OF COMPETITION
TABLE 569
ANATOMIC PATHOLOGY MARKET: REGION FOOTPRINT
TABLE 570
ANATOMIC PATHOLOGY MARKET: TYPE FOOTPRINT
TABLE 571
ANATOMIC PATHOLOGY MARKET: PROCESS FOOTPRINT
TABLE 572
ANATOMIC PATHOLOGY MARKET: END-USER FOOTPRINT
TABLE 573
ANATOMICAL PATHOLOGY MARKET: DETAILED LIST OF KEY STARTUPS/SMES
TABLE 574
ANATOMIC PATHOLOGY MARKET: COMPETITIVE BENCHMARKING OF STARTUPS/SMES (1/2)
TABLE 575
ANATOMIC PATHOLOGY MARKET: COMPETITIVE BENCHMARKING OF STARTUPS/ SMES (2/2)
TABLE 576
ANATOMIC PATHOLOGY MARKET: PRODUCT LAUNCHES & APPROVALS, JANUARY 2023– JULY 2026
TABLE 577
ANATOMIC PATHOLOGY MARKET: DEALS, JANUARY 2023–JULY 2026
TABLE 578
ANATOMIC PATHOLOGY MARKET: EXPANSIONS, JANUARY 2023– JULY 2026
TABLE 579
F. HOFFMANN-LA ROCHE LTD.: COMPANY OVERVIEW
TABLE 580
F. HOFFMANN-LA ROCHE LTD.: PRODUCTS OFFERED
TABLE 581
F. HOFFMAN-LA ROCHE LTD.: PRODUCT LAUNCHES & APPROVALS, JANUARY 2023–JULY 2026
TABLE 582
F. HOFFMAN-LA ROCHE LTD.: DEALS, JANUARY 2023–JULY 2026
TABLE 583
DANAHER CORPORATION: COMPANY OVERVIEW
TABLE 584
DANAHER: PRODUCTS OFFERED
TABLE 585
DANAHER CORPORATION: PRODUCT LAUNCHES & APPROVALS, JANUARY 2023–JULY 2026
TABLE 586
DANAHER CORPORATION: DEALS, JANUARY 2023–JULY 2026
TABLE 587
PHC HOLDINGS CORPORATION: COMPANY OVERVIEW
TABLE 588
PHC HOLDINGS CORPORATION: PRODUCTS OFFERED
TABLE 589
PHC HOLDINGS CORPORATION: PRODUCT LAUNCHES & APPROVALS, JANUARY 2022–OCTOBER 2025
TABLE 590
PHC HOLDINGS CORPORATION: DEALS, JANUARY 2022–OCTOBER 2025
TABLE 591
AGILENT TECHNOLOGIES, INC.: COMPANY OVERVIEW
TABLE 592
AGILENT TECHNOLOGIES, INC.: PRODUCTS OFFERED
TABLE 593
AGILENT TECHNOLOGIES, INC.: PRODUCT LAUNCHES, JANUARY 2023–JULY 2026
TABLE 594
AGILENT TECHNOLOGIES, INC.: DEALS, JANUARY 2023–JULY 2026
TABLE 595
HOLOGIC INC.: COMPANY OVERVIEW
TABLE 596
HOLOGIC INC.: PRODUCTS OFFERED
TABLE 597
HOLOGIC, INC.: PRODUCT APPROVALS, JANUARY 2023–JULY 2026
TABLE 598
BECTON, DICKINSON AND COMPANY (BD): COMPANY OVERVIEW
TABLE 599
BECTON, DICKINSON AND COMPANY (BD): PRODUCTS OFFERED
TABLE 600
BECTON, DICKINSON AND COMPANY: DEALS, JANUARY 2023–JULY 2026
TABLE 601
BECTON, DICKINSON AND COMPANY: EXPANSIONS, JANUARY 2023–JULY 2026
TABLE 602
KONINKLIJKE PHILIPS N.V: COMPANY OVERVIEW
TABLE 603
KONINKLIJKE PHILIPS N.V.: PRODUCTS OFFERED
TABLE 604
KONINKLIJKE PHILIPS N.V.: DEALS, JANUARY 2023–JULY 2026
TABLE 605
KONINKLIJKE PHILIPS N.V.: EXPANSIONS, JANUARY 2023–JULY 2026
TABLE 606
MERCK KGAA: COMPANY OVERVIEW
TABLE 607
MERCK KGAA: PRODUCTS OFFERED
TABLE 608
MERCK KGAA: EXPANSIONS, JANUARY 2023–JULY 2026
TABLE 609
SECTRA AB: COMPANY OVERVIEW
TABLE 610
SECTRA AB: PRODUCTS OFFERED
TABLE 611
SECTRA AB: PRODUCT APPROVALS, JANUARY 2023–JULY 2026
TABLE 612
SECTRA AB: DEALS, JANUARY 2023–JULY 2026
TABLE 613
SECTRA AB: EXPANSIONS, JANUARY 2023–JULY 2026
TABLE 614
SAKURA FINETEK JAPAN CO., LTD.: COMPANY OVERVIEW
TABLE 615
SAKURA FINETEK JAPAN CO., LTD.: PRODUCTS OFFERED
TABLE 616
SAKURA FINETEK JAPAN CO., LTD.: PRODUCT LAUNCHES, JANUARY 2023–JULY 2026
TABLE 617
SAKURA FINETEK JAPAN CO., LTD.: DEALS, JANUARY 2023–JULY 2026
TABLE 618
SAKURA FINETEK JAPAN CO., LTD.: EXPANSIONS, JANUARY 2023–JULY 2026
TABLE 619
BIO SB: COMPANY OVERVIEW
TABLE 620
BIOGENEX: COMPANY OVERVIEW
TABLE 621
MILESTONE MEDICAL: COMPANY OVERVIEW
TABLE 622
HISTO-LINE LABORATORIES: COMPANY OVERVIEW
TABLE 623
DIAPATH S.P.A.: COMPANY OVERVIEW
TABLE 624
SLEE MEDICAL GMBH: COMPANY OVERVIEW
TABLE 625
AMOS SCIENTIFIC PTY LTD.: COMPANY OVERVIEW
TABLE 626
MEDITE MEDICAL GMBH: COMPANY OVERVIEW
TABLE 627
CELL SIGNALING TECHNOLOGY, INC.: COMPANY OVERVIEW
TABLE 628
CELLPATH LTD.: COMPANY OVERVIEW
TABLE 629
MICROS AUSTRIA: COMPANY OVERVIEW
TABLE 630
R. K. SCIENTIFIC INSTRUMENT PRIVATE LIMITED: COMPANY OVERVIEW
TABLE 631
RWD LIFE SCIENCE CO., LTD.: COMPANY OVERVIEW
TABLE 632
MEDIMEAS: COMPANY OVERVIEW
TABLE 633
BRIGHT INSTRUMENTS: COMPANY OVERVIEW
TABLE 634
JINHUA YIDI MEDICAL APPLIANCE CO., LTD.: COMPANY OVERVIEW
TABLE 635
HAMAMATSU PHOTONICS K.K.: COMPANY OVERVIEW
TABLE 636
3DHISTECH LTD.: COMPANY OVERVIEW
TABLE 637
OPTRASCAN: COMPANY OVERVIEW
TABLE 638
DAKEWE: COMPANY OVERVIEW
TABLE 639
KEY DATA FROM PRIMARY SOURCES
TABLE 640
ANATOMIC PATHOLOGY MARKET: RISK ASSESSMENT
FIGURE 1
ANATOMIC PATHOLOGY MARKET SEGMENTATION & REGIONAL SCOPE
FIGURE 2
KEY INSIGHTS & MARKET HIGHLIGHTS
FIGURE 3
GLOBAL ANATOMIC PATHOLOGY MARKET, 2024–2031
FIGURE 4
MAJOR STRATEGIES ADOPTED BY KEY PLAYERS IN ANATOMIC PATHOLOGY MARKET, 2023–2025
FIGURE 5
DISRUPTIVE TRENDS IMPACTING GROWTH OF ANATOMIC PATHOLOGY MARKET
FIGURE 6
HIGH-GROWTH SEGMENTS & EMERGING FRONTIERS IN ANATOMIC PATHOLOGY MARKET, 2025
FIGURE 7
ASIA PACIFIC TO REGISTER HIGHEST GROWTH DURING FORECAST PERIOD
FIGURE 8
RISING CASES OF CANCER TO DRIVE MARKET GROWTH DURING FORECAST PERIOD
FIGURE 9
CONSUMABLES SEGMENT TO DOMINATE MARKET DURING FORECAST PERIOD
FIGURE 10
PREANALYTICS/SAMPLE PREPARATION SEGMENT TO LEAD MARKET DURING FORECAST PERIOD
FIGURE 11
BREAST CANCER SEGMENT TO LEAD MARKET DURING FORECAST PERIOD
FIGURE 12
HOSPITALS SEGMENT TO LEAD MARKET DURING FORECAST PERIOD
FIGURE 13
ASIA PACIFIC TO REGISTER HIGHEST GROWTH DURING FORECAST PERIOD
FIGURE 14
ANATOMIC PATHOLOGY MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
FIGURE 15
ANATOMIC PATHOLOGY MARKET: PORTER’S FIVE FORCES ANALYSIS
FIGURE 16
ANATOMIC PATHOLOGY MARKET: SUPPLY CHAIN ANALYSIS
FIGURE 17
ANATOMIC PATHOLOGY MARKET: VALUE CHAIN ANALYSIS
FIGURE 18
ANATOMIC PATHOLOGY MARKET: ECOSYSTEM ANALYSIS
FIGURE 19
ANATOMIC PATHOLOGY MARKET: TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES
FIGURE 20
NUMBER OF DEALS & FUNDING ACTIVITIES IN ANATOMIC PATHOLOGY MARKET
FIGURE 21
PATENT ANALYSIS FOR ANATOMIC PATHOLOGY, JANUARY 2016–DECEMBER 2025
FIGURE 22
MARKET POTENTIAL OF AI IN ANATOMIC PATHOLOGY MARKET
FIGURE 23
INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS, BY END USER
FIGURE 24
KEY BUYING CRITERIA, BY END USER
FIGURE 25
NORTH AMERICA: ANATOMIC PATHOLOGY MARKET SNAPSHOT
FIGURE 26
ASIA PACIFIC: ANATOMIC PATHOLOGY MARKET SNAPSHOT
FIGURE 27
REVENUE ANALYSIS OF KEY PLAYERS IN ANATOMIC PATHOLOGY MARKET, 2023–2025 (USD MILLION)
FIGURE 28
ANATOMIC PATHOLOGY MARKET SHARE ANALYSIS, 2025 (GLOBAL)
FIGURE 29
ANATOMIC PATHOLOGY MARKET SHARE ANALYSIS, 2025 (US)
FIGURE 30
ANATOMIC PATHOLOGY MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2025
FIGURE 31
ANATOMIC PATHOLOGY MARKET: COMPANY FOOTPRINT
FIGURE 32
ANATOMIC PATHOLOGY MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2025
FIGURE 33
EV/EBITDA OF KEY VENDORS
FIGURE 34
YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF KEY VENDORS
FIGURE 35
ANATOMIC PATHOLOGY MARKET: BRAND/PRODUCT COMPARISON FOR ANATOMIC PATHOLOGY
FIGURE 36
F. HOFFMANN-LA ROCHE LTD.: COMPANY SNAPSHOT (2025)
FIGURE 37
DANAHER CORPORATION: COMPANY SNAPSHOT (2025)
FIGURE 38
PHC HOLDINGS CORPORATION: COMPANY SNAPSHOT (2025)
FIGURE 39
AGILENT TECHNOLOGIES, INC.: COMPANY SNAPSHOT (2025)
FIGURE 40
HOLOGIC INC.: COMPANY SNAPSHOT (2025)
FIGURE 41
BECTON, DICKINSON AND COMPANY (BD): COMPANY SNAPSHOT (2025)
FIGURE 42
KONINKLIJKE PHILIPS N.V.: COMPANY SNAPSHOT (2025)
FIGURE 43
MERCK KGAA: COMPANY SNAPSHOT (2025)
FIGURE 44
SECTRA AB: COMPANY SNAPSHOT (2025)
FIGURE 45
RESEARCH DESIGN
FIGURE 46
LIST OF PRIMARY SOURCES
FIGURE 47
KEY INDUSTRY INSIGHTS
FIGURE 48
BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
FIGURE 49
APPROACH 1: REVENUE ESTIMATION OF KEY PLAYERS
FIGURE 50
CAGR PROJECTIONS
FIGURE 51
TOP-DOWN APPROACH
FIGURE 52
DATA TRIANGULATION
Methodology
The objective of this study is to analyze the key dynamics influencing the anatomic pathology market, including drivers, restraints, opportunities, challenges, and emerging technology trends. The study also evaluates competitive developments such as product launches, regulatory approvals, acquisitions, partnerships, collaborations, and geographic expansions undertaken by leading market participants. Furthermore, it assesses the competitive landscape of the anatomic pathology market by profiling key players and benchmarking them across various business and product strategy parameters. Both top-down and bottom-up approaches were employed to estimate the overall market size, while market breakdown and data triangulation methodologies were used to validate the size of individual segments and subsegments and ensure the accuracy of market estimates.
The four steps involved in estimating the market size are as follows:
Secondary research for the anatomic pathology market drew on a wide range of credible commercial and regulatory sources, including Bloomberg Business, Factiva, and Dun & Bradstreet for corporate financial and operational data. White papers, scientific publications, annual reports, investor presentations, and SEC filings provided additional context on product pipelines, revenue structures, and market positioning. Regulatory databases were used to track device clearances and approvals in key geographies.
Primary ResearchIn the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. Supply-side primary interviews were conducted with project managers, product managers, sales directors, vice presidents of diagnostics, CEOs, and business development directors at manufacturers of anatomic pathology products, as well as reagent kit suppliers, laboratory automation vendors, and IVD distributors. Demand-side primary interviews covered laboratory directors and clinical pathologists at hospital and reference laboratories, research laboratory managers, health clinic directors, academic research scientists, and procurement officers at pharmaceutical and biotechnology companies.
The following is a breakdown of the primary respondents:
Note: Others include sales, marketing, and product managers.
Companies are classified into tiers based on their total revenues. As of 2025, Tier 1 = >USD 100 million, Tier 2 = USD 10 million to USD 100 million, and Tier 3 = <USD 10 million.
|
COMPANY NAME |
DESIGNATION |
|
Danaher Corporation (US) |
Sales Manager |
|
F. Hoffmann-La Roche AG (Switzerland) |
Product Manager |
To know about the assumptions considered for the study, download the pdf brochure
Market Size Estimation
Anatomic Pathology Market : Top-Down and Bottom-Up Approach
Both top-down and bottom-up approaches were used to estimate and validate the anatomic pathology market’s total size. These methods were also used extensively to estimate the size of various subsegments in the market. The research methodology used to estimate the market size includes the following:
- The key players in the industry have been identified through extensive secondary research
- The revenues generated by leading players operating in the anatomic pathology market were determined through primary and secondary research.
- All percentage shares, splits, and breakdowns have been determined using secondary sources and verified through primary sources.
Data Triangulation
After arriving at the overall market size by applying the process mentioned above, the total market was split into several segments and subsegments. The data triangulation and market breakdown procedures were employed to validate and complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments of the anatomic pathology market. The data was triangulated by studying various factors and trends from the demand and supply sides in the anatomic pathology market.
Market Definition
Anatomic pathology is a subspeciality of pathology that focuses on the diagnosis and characterization of diseases through the examination of organs, tissues, cells, and bodily fluids obtained from patients through biopsies, surgical procedures, and other sampling methods. Anatomic pathology testing (APT) encompasses the range of diagnostic technologies, products, and services used within this field, including histopathology, cytopathology, digital pathology and amongst others. These techniques play a critical role in the detection, classification, prognosis, and monitoring of cancer, infectious diseases, and other medical conditions, supporting clinical decision-making and personalized treatment strategies.
Key Stakeholders
- Product Manufacturers, Distributors, and Suppliers
- Diagnostic Laboratories and Clinical Laboratories
- Research Laboratories and CROs
- Academic Universities and Medical Research Centers
- Research and Development (R&D) Centers
- Pharmaceutical and Biotechnology Companies
- Anatomic Pathology Companies
- Market Research and Consulting Firms
- Government Associations
Report Objectives
- To define, describe, and forecast the anatomic pathology product market (type, process, disease, end user, and region), Service market (type, model, disease)
- To provide detailed information about the key factors influencing the growth of the Anatomic Pathology Market (drivers, restraints, opportunities, and challenges)
- To analyze the micromarkets with respect to individual growth trends, prospects, and contributions to the overall market
- To analyze market opportunities for stakeholders and provide the competitive landscape details of the key players
- To forecast the revenue of market segments across five main regions: North America, Europe, Asia Pacific, Latin America, and Middle East & Africa
- To profile the key players of the Anatomic Pathology Market and comprehensively analyze their core competencies and market shares
- To benchmark players within the market using the proprietary Company Evaluation Matrix framework, which analyzes market players on various parameters within the broad categories of business and product excellence
- To study the impact of AI on the market, along with the macroeconomic outlook for each region
Available customizations:
Company Profiles
MarketsandMarkets offers the following customizations for this market report.
Company Information- Additional country-level analysis of the anatomic pathology market
- Additional five company profiles of players operating in the anatomic pathology market.
Product Analysis
-
Product matrix, which provides a detailed comparison of the product portfolio of each company in the anatomic pathology market
Personalize This Research
- Triangulate with your Own Data
- Get Data as per your Format and Definition
- Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
- Any level of Personalization
Let Us Help You
- What are the Known and Unknown Adjacencies Impacting the Anatomic Pathology Market
- What will your New Revenue Sources be?
- Who will be your Top Customer; what will make them switch?
- Defend your Market Share or Win Competitors
- Get a Scorecard for Target Partners
Director of Market Insights, Data and Analytics
SFI Health,
Leading Pharmaceutical Company
We at SFI Health approached MarketsandMarkets for an Opportunity Assessment on "Incidence and Prevalence of Focus Indications" as we wanted to know the most attractive HCPs like Physician, Functional MD, Naturopath and Pharmacist. The project was critical for us to ensure our focus on the right target which would enable sustainable growth and profitability for SFI Health. The business insights provided exceeded our expectations and we were extremely impressed. The team at MarketsandMarkets is highly professional and detail oriented and very well understood our business needs. MarketsandMarkets offers a unique combination of expertise and dedicated engagement model. We identified 2 new products to be launched in coming months, based on the research findings provided by MarketsandMarkets. We are happy with the services and would strongly recommend MarketsandMarkets to my peers in the industry.
Head of Commercial Analytics
Qualicaps,
Leading Pharmaceutical Company
We partnered with MarketsandMarkets for an assessment study on hard empty capsules. The team was extremely professional in understanding our business requirements and we received timely responses to all our queries. The market intelligence and the recommendations has met our business requirements. We were extremely impressed to see the final study results; it really exceeded our expectations. The market intelligence offered by MarketsandMarkets, and clarity on next steps will help us achieve our business objective for the Year 2021. We are happy with the services and would strongly recommend MarketsandMarkets to my peers in the industry.
Senior Director Business Development & Innovation
Bracco Diagnostics Inc.,
Italian Multinational in life sciences sector and a World Leader in imaging diagnostics
We were pleased with targeted insights that MarketsandMarkets identified from a custom study on the 'Radiation Dose Management Solutions Market'. Your team identified and characterized the market participants as well as underlying trends accurately. This study was useful to Bracco in formulating business strategies for our dose monitoring product lines and we thank MarketsandMarkets for the job well done.
Market Development and Strategy Manager
3M Health Information Systems,
Leader in Health care Coding, Payment & Analytics Solutions.
The value for our organization comes from three things: depth of research, specificity of segments and being easy to work with. As important as the first two are, the third can't be underestimated. MarketsandMarkets, maybe more than any other research vendor, wants to know what is top of mind for our team and what big questions we are grappling to answer.
Their customer first approach and high value engagement model, have given us great analysis and excellent value for money
Схожие новости
Классификация: Пресс-релизы. Схожих патентов: 0. Схожих новостей: 10. Тональность: 0. Информативность: 11.67. Источник: www.marketsandmarkets.com.